SOAD KHALIL AL JAOUNI, MD, FRCPC

Name	PROF. DR. SOAD KHALIL AL JAOUNI, MD, FRCPC
Nationality	Saudi
Address	Department of Haematology Faculty of Medicine King Abdulaziz University (KAU) “Medical Center” P.O. Box 80215 Jeddah 21589 Saudi Arabia
TEL	+ 966-2-640-1000 ext. 17047 (Hematology sec) + 966-2-640-1000 ext. 17046 (Office)
FAX	+ 966-12-640-8034
E-MAIL	saljaouni@kau.edu.sa dr.jaouni@gmail.com

Saudi Commission for Health Specialties #06-J-M-27130 (double qualified)

Professor & Consultant of Hematology and Professor& Consultant of Pediatric Hematology/ Oncology, more than 28 years experience as a double qualified Hematologist/Pediatric Oncology Deputy Chairman of Hematology Department Head Division of Pediatric Hematology/Oncology

2009 up to present	Professor & Consultant of Hematology and Professor& Consultant of Pediatric Hematology/ Oncology, more than 30 years experience as a double qualified Hematologist/Pediatric Oncology Deputy Chairman of Hematology Department Head Division of Pediatric Hematology/Oncology
2003 -2009	: Associate Professor in Hematology Consultant Hematologist, Pediatric Hematology/Oncology King Abdulaziz University, Jeddah, Saudi Arabia
1991 to 2003	Assisstend Profasser, Consultant Hematologist &Pediatric Hematology/ Oncology Senior Lecturer and Researcher at Hematology Departement, Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia
1993 to present	Head, Division of Pediatric Hematology/Oncology at King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia.
1996	King Fahd Armed Forces Military Hospital (KFMH), Jeddah, Saudi Arabia   Acting Head, Director of the Laboratories /King Fahd Armed  Forces Military Hospital (for 45 days each year)   Clinical Coordinator for Saudi Medical Personnel   Member of Quality Assurance and Clinical Audit Initiate and in-charge of transfusion committee.  Initiate neonatal screening program of sickle cell haemoglobinopathies and thalassemia disorders at the King Fahd Armed Forces Military Hospital. 1996.
1999 to March 2001	Head of the Hematology Research Laboratory at the King Fahd Medical Research Center, KAU.
2001 to Present	Head of Diagnostic Unit for Inherited Blood Disorders at the Haematology Laboratory in King Abdulaziz UniversityHospital, Jeddah, Saudi Arabia
July 2002	Acting chairman of Hematology Department at King Abdulaziz University Hospital (KAUH).
February 2002 to March 2003	Coordinator of Post-Graduate for MRCPath (U.K.) at King Abdul Aziz University Hosp.
March 2003 to present	Director of Hematology/Oncology Task Force in Haematology Department. (KAUH)
July 2003 & July 2005	Acting Chairman of Hematology Department King Abdulaziz University Hospital, Jeddah, Saudi Arabia
2005 to present	Member of Bioethical and Research Committee at King Abdulaziz University Hospital, Jeddah, Saudi
2007 to present	Treasurer and Executive Board Member of the Saudi Society of Hematology
2008 to 2016	Executive Board Member of the Saudi Thalassemia Society, Head of Scientific Committee of the Society
2010 to 2016	Member of Biomedical Ethics Unit
2016 up to present	Member of Editorial Board of the Journal of Applied Hematology    Member of Editorial Board of the Current Pediatric Research Journal Member of Editorial Board of Biomedicines Journal Member of Editorial Board of Endo-Thal
Oct. 2016 up to present	President of the Saudi Society of Hematology
January 7-10, 2018	Member of selection committee of King Faisal International Prize in Medicine.
2012-up to 2018	Director & Chief Executive Officer of Scientific Chair of Yousef Abdul Latif Jameel Prophetic Medicine Applications
November 2018 to present	Director & Chief Executive Officer for the Center of Excellency in Research for Prophetic Medicine Application

November 1989        Certificate of Royal College of Physician and Surgeon of Canada             

                                   Specialist Certificate in Hematology, Toronto University Canada

February 1990          Fellow of the Royal College of Physician of Canada in Division

                                   of Medicine 1990.

December 1990         Fellowship of Pediatric Hematology/Oncology, from Sick kid                  

                                   Toronto University Canada.

March 2006               Fellow of the Royal College of Physicians and Surgeons of

                                   Canada, FRCPC

2000- 2005                Maintenance of Certification of Royal College of Physician of Canada MOC

  Jan. 1990                Clinical Fellowship in Pediatrics Hematology / Oncology at Sick Children  

                                  Hospital, University of Toronto, Canada.

July, 1988                 Resident in the departmend of Pediatrics Hematology / Oncology

September 1984      M.C.C.E.E.Canada. 

June 1981                M.B. Ch.B. (MD) First Graduate of Female Section, College of Medicine  

                                  King Abdulaziz University, College of Medicine& Allied Science, Jeddah,  

                                  Saudi Arabia

Certificate of Completions Apr. 22.2014

*Course Overview & Overview of ICH Good Clinical Practice,

*Clinical Investigator Obligations & Qualifications, Resources, IRBs/IECs,                                             

*Subject Informed Consent & Protocol Compliance,

  * Investigational Product, Randomization, and Unblinding & Source Documents and Case  

    Report Form Completion,

* Safety Reporting, Financial Disclosure, & Study Closeout, Trial Termination, and Record    

    Retention

  *Non-compliance, Scientific Misconduct and Fraud & Monitoring and Preparing for Audits and  

    Inspections April 22, 2014 by Quintiles Global Talent, Development & Engagement 

* Certificate of Appreciation Thomson Reuters, Web of Science, Journal Citations Reports and

   End Note training workshops on February 4, 2016at KAUH

July 1989 – Dec. 1990	Clinical Fellow in Hematology at Sunnybrook Medical Center and Pediatric Hematology/Oncology at Hospital for Sick Children University of Toronto, Ontario, Canada
July 1988 – June 1989	Resident in Pediatric Haematology / Oncology (R4) Hospital for Sick Children University of Toronto, Ontario, Canada
July 1985 – June 1988	Resident in Pediatrics Department (IWK Hospital) (R1) & Resident in Internal Medicine / Hematology (VGH, Camp Hill)(R2-3) Dalhousie University, Halifax, Nova Scotia, Canada
July 1982 – May 1984	Resident in Pediatrics King Abdulaziz University Hospital, Jeddah, Saudi Arabia
July 1981 – 1982	Rotating Internship King Abdulaziz University Hospital, Jeddah, Saudi Arabia

* The Canadian Paediatric Society (1988)
* The American Society of Pediatrics Hematology / Oncology (1989)
* Fellow of the Royal College of Physicians and Surgeons in Division of Medicine of Canada, 1990
* The American Association of Blood Bank (1990)
* European Hematology Association #4328 (2005) to present
* American Hematology Association #1009805 (2006)
* Member of Egyptian Society of Pediatric Hematology / Oncology

---

↑ Go to Top

* Saudi Commission for Health Specialties #06-J-M-27130 (double qualified)

* Saudi Heart Association, National CPR Committee Certificate of Cardiopulmonary Resuscitation.

* 2006 Founder and Executive Board Member of the Saudi Society of Hematology and Treasurer.

* Associate Editor in the Editorial Board in the Journal of Applied Hematology.

* Founder and Executive Board Member in the Saudi Society of Thalassaemia and Sickle Cell Anaemia.

* Member in the Saudi Arabian Pediatric Hematology/Oncology Society (SAPHOS)

* Member in the Saudi Society of Oncology.

* Founding Member of the Saudi Medical Laboratories

* Member in the Saudi Tumor National Registry

* Member of the National Project to Prevent Hereditary Blood Disease

* Director of Research in International of Scientific Signs in Eajaz Women's Commission, Jeddah.

1. Al Jaouni SK, Ross G, Bernard L. I.V. Gamma Immunoglobulin treatment, comparing pediatric and adult patients in chronic I.T.P.  Dalhousie University Research, Halifax, Canada. May 1988.

 

2. Al Jaouni SK, Pinkerton PH, Sheidan BL. Breakpoints involved in deletion of long arm of chromosome 5 in myelodysplasia and acute non-lymphoblastic leukemia do not correlate with the morphological diagnosis. Leukemia & Lymphoma, 1990; 3:  195-200. ISSN: 1042-8194 (print); 1029-2403 (web)

 

3. Gazzaz FS, Mosli H, Al Jaouni SK, et al. Cytomeglouirus infection among children with blood malignancies.  Saudi Med J 1997; 18(5):  476-479.

 

4. Al Jaouni SK. Prevalence of antibodies to human T-lymphotrophic virus types I and II amongst Saudi Arabian blood donors.  Ann Saudi Med 2000; 20(2):  155-156.

 

5. Al Jaouni SK. Primary thrombophilia in Saudi Arabia. Saudi Med J 2003; 24(6):  614-616. This article had been  selected August 20, 2011 in Bio Med Library as Top 10 Published in this domain.

 

6. Al Jaouni SK, Gari M, Damanhouri G, Fadlalah M, Jarullah J. Chromatographic Phenotypes Distribution of Neonatal Thalassemia & Sickle Cell Anemia in Hospital Births in Jeddah area, Saudi Arabia.  Egyptian J Pediat 2003; 20 (3/4):  595-605.

 

7. Al Jaouni SK, Gari MH, Damanhouri GA, Fadlalah, M. Neonatal Screening for hemoglobinopathies Using High-Performance Liquid Chromatography.  The Second Annual Meeting for Scientific Research.  Scientific Publishing Centre, King Abdulaziz University, Jeddah.  31/3/2003:  153-164.   ISBN: 9960-06-365-8.

 

8. Al-Muhayawi, Al-Jaouni SK. Adenotonsillectomy in Children with Sickle Cell Anemia Without Pre-Operative Blood Transfusion. Saudi Journal of Oto-Rhino-Laryngology, 2005;7(2):68-71.

 

9. Al Jaouni SK, Al Sayes F. Systemic Mastocytosis Recent Advances in Management and Treatment – Hematological View. Egyptian Journal of Pediatrics 2006 23 Pge (1 & 2), 97-104.

 

10. Al-Jaouni SK, Al-Muhayawi SM, Qari M, Abu Nawas M. Safety of Avoiding Peri-Operative Transfusion in Sickle Anemia. 11^th Congress of the Europeani Hematology Association. HAEMATOLOGICA 2006;91(supplement 1) impact factor: 5.516

 

11. Al Jaouni SK. Molecular Characterization and Clinical Significance of G6PD Deficiency in Western Saudi Arabia. 11^th Congress of the Europeani Hematology Association.  HAEMATOLOGICA 2006;91(supplement 1). impact factor: 5.516

 

12. Al Jaouni SK. Studies on Survival and Disease Complication of Thalassemia Major, Experience of 14 years at King Abdulaziz University Hospital. 11^th Congress of the Europeani Hematology Association.  HAEMATOLOGICA 2006;91(supplement 1) impact factor: 5.516

 

13. Al Jaouni SK, Al Muhayawi, SM, Qari MH, Abu Nawas M, Mazroh A. Randomized Clinical Trial to Evaluate the Safety of Avoiding Pre-operative Transfusion in Sickle Cell Anemia. Bahrain Medical Bulletin vol. 28 #4 December 2006:164-167. impact factor: 125

 

14. Al Jaouni SK, Qari M., Ashankyty, I.,Al-Mahayawi, S, Jarullah, J. Glucose 6 Phosphate Dehydrogenase Deficiency Correlation between Genotype and Phenotype. Journal of King Abdulaziz University, Medical Sciences JKAU: Med. Sci. Vol.14 No. 2, pp:3-13 (2007 A.D. / 1428 A.H.).

 

15. Al Jaouni SK, Al Jedani H. Hematopoietic Colon Stimulating Factors Can Cause Cataract. Haematologica June 2007; vol. 92(suppl 1) pp 542. . impact factor: 5.516

 

16. Al Jaouni SK. The Pattern of Bone Disease and It's Morbidity Among Thalassemia Treated at a Single Institute in Saudi Arabia. Haematologica June 2007; vol. 92(suppl 1) pp 428-429. . impact factor: 5.516

 

17. Al Jaouni SK, Al Agha AM, Hussein, A, Ashoor S. Prevalence of Bone Diseases in Pediatric Hematology/Oncology Patients. Haematological June 2007; vol. 92(suppl1)

        impact factor: 5.516

 

18. Qari M, Al Jaouni SK, AlSayes F, Fatani H, Mousa S. Reduction of Painful Vaso-Occlusive Crisis of SCA by Tinzaparin in Double Blind Randomized Trial. Thrombosis and Hemostasis Journal 2007; 98:392-396. Impact factor:4.899

 

19. Al Jaouni SK. Serum Ferritin is a Poor Indicator of Myocardial Iron Content in Early Stage of Iron Overload in Thalassemia Major. The Egyptian Journal of Haematology, Volume (32), Number (3) June 2007; page 171-176.

 

20. Al Jaouni SK, Fida N Prevalence of bone disease in children & adolescents with SCA single institute experience in KSA, Haematological June 2008; 93 (S1) page 519 . impact factor: 5.516

 

21. Al Jaouni SK, Successful management of refractory severe thrombocytopenia associated with antiphospholipid syndrome using rituximals, Blood Journal of American Society of Hematology; November 16, Volume 113 No. 11, 2008. 50^th American Society of Hematology, San Francisco California, Blood Journal December 6-9, 2008.  #4570. impact factor:10.37

 

22. Al Jaouni SK, Using Noval experimental PM 701 in refractory Hodgkin Disease control with conventional therapy. Blood November 16, Volume 113 No. 11 2008  50^th American Society of Hematology, San Francisco California, Blood Journal  December 6-9, 2008.#4677. impact factor:10.37

 

23. El bostany Eman, Al Jaouni SK. Spectrum of inherited bleeding disorders in pediatrics..Blood Coagulation and Fibrinolysis. 19(8):771-775, December 2008. impact factor: 0.583

 

24. A. Raouf, W. A. Ekhateeb, Al Jaouni SK, H. Toma, M. Qari, K. Elkebba, T. A. Kumosani. Infrared Spectroscopy of Human Bone Marrow: Evidence of Structural Changes During Acute Leukemia. Int. J.  Nano and Biomaterials, Vol. 2, Nos. 1/2/3/4/5, 2009. pp.289-298.

 

25. Al Jaouni SK, Prevalence of bone diseases among hematological disorders. XX^th Congress of International Society of Haematology (ISH) European and African Division (EAD), Oct. 10^th -13^th, 2009. Presented as proceeding.

 

26. Al Jaouni SK, Neonatal Screening of Glucose-6-Phosphate Dehydrogenase Deficiency Diagnostic Challenge and Clinical Significance. Egyptian Journal of Pediatrics, Vol. 26, No. 4 (December), 873-886, 2009 .

 

27. Al Jaouni SK, Al-Agha AM, Hussein A, Ashoor S. Prevalence of bone disease in Pediatric Hematology/Oncology patients. Haematologica-The Hematology Journal Vol. 94; Jun 2009; pp.566-567. impact factor: 5.516

 

28. Mousa SA, Al-Momen AK, Al Sayegh F, Al Jaouni SK, Nasrullah Za, Al Saeed H, Alabdullatif A, Al Sayegh M, Al Zahrani H, Higazi M, Alsulaiman A, Qari MH, Review: Management of painful vaso-occlusive crisis of sickle cell anemia: Consensus opinion. Clinical and Applied Thrombosis/Hemostasis 2010. pp. 365-376. Impact Factor : 1.332

 

29. Al Jaouni SK , Review Article: Severe Congenital Neutropenia (Kostmann Syndrome). The Egyption Journal of Medical Human Genetics(ESHG) 2010. pp. 1-9. Publication and hosting by Elsevier.

 

30. Al Jaouni SK, Prevalence of Thalassemia Disorders and Hemoglobinopathies in Jeddah, Western Saudi Arabia. Journal of Applied Hematology 2010:Vol.1(1)43-46.

 

31. Al Jaouni SK, Al Muhayawi, MS, El-Deek, B, Medical Students awareness about neonatal screening program of the hemoglobin disorders and G6PD deficiency in Jeddah, Western Saudi Arabia. Presented as proceeding in 3^rd Pan Arab Human Genetics Conference, March 13-14, 2010.

 

32. Al Jaouni SK. Jarallah, J., Molecular Diagnostic of G6PD deficiency among Saudi population in Jeddah, Kingdom of Saudi Arabia. Presented as proceeding in 3^rd Pan Arab Human Genetics Conference, March 13-14, 2010.

 

33. Al Jaouni SK, Aljedani Hanadi HM, Cataract associated with high dose hematopoietic colony stimulating factor, case report and literature review. Saudi Pharmaceutical Journal; Volume 18 No. 2, April 2010 pp. 107-110. Publication and hosting by Elsevier. Impact Factor: 3.110

 

34. Al Jaouni SK. Studies on Survival and Disease Complication of Thalassemia Major, Experience of 14 years at King Abdul Aziz University Hospital. JKAU: Med. Sci., Vol. 17 No. 1. pp. 19-28. 2010.

 

35. Al Jaouni SK. The Prevalence of the primary thrombophilia among the Saudi population attending anti-coagulant clinic 10 years' experience. Presented as a Poster at 21^st International Congress on Thrombosis, in Milan, Italy July 6-9, 2010. Journal Of Thrombosis And Haemostasis, Impact Factor : 5.731

 

36. Al Jaouni SK, Prevalence pf Thalassemia Disorders and Hemoglobinopathies in Jeddha, Western Saudi Arabia. Journal of Applied Hematology. Vol. 1. No. 1. September 2010. pp.43-46.

 

37. Raouf Gehan A., Al Jaouni SK, Novel Methodology in Detecting Minimal Residual Disease in Acute Lymphoblastic Leukemia by FTIR Spectroscopy. Journal of Applied Hematology. Vol. 1, Issue 2, December, 2010. pp. 102-107.

 

38. Al Jaouni SK., Hussein A., Elfiki I, Al Muhayawi M. Honey reduces chemoradiotherapy-induced mucositis in pediatric cancer patients. Accepted as a proceedings in European School of Hematology ESH International Conference An update on the management of haematological malignancies. March 25-27, 2011.

 

39. Al Muhawayi , Al Jaouni SK., Halawa T. The quality of life of sickle cell anemia and the prevalence of bone diseases. Accepted as proceedings on 12th  International Conference  on Thalassemia and the haemoglobinopathies. May 11-14, 2011, Antalia, Turkey. Poster No. 187; p.120.

 

Jaouni SK., Hussein A., Elfiki I. Using a new integrative approach with sixteen refractory cases in Pediatric Hematology/ Oncology at King Abdulaziz University Hospital in Saudia. Accepted as abstract in European Hematology Association (EHA). June, 2011.

 

41. Al-Agha, A., Shabakah, SA., Ocheltree, A., Abdullatif, DM., Al Jaouni, SK. Endocrinopathies in Children and Adolescents with b-Thalassemia Major. Journal of Applied Hematology. Vol. 2, Issue 1, March pp. 20-24.

 

42. Al Jaouni SK., Jarullah, JM., Azhar EI.,  Moradkhani K., Molecular Characterization of Glucose-6=Phosphate Dehydrogenase Deficiency in Jeddah, KSA. BMC Research Notes. 4:436. doi: 10.1186/1756-0500-4-436. (Top 20 publication by BioMed Lib 2012). Impact Factor: 2.7

 

43. Selim, S., Alfy, S., Ruwaili, M., Abdo, A., Al Jaouni, SK. Susceptibility of imipenem-resistant Pseudomonas aeruginosa to flavonoid glycosides of date palm (Phoenix dactylifera L.) tamar Growing in Al Madinah, Saudi Arabia, African Journal of Biotechnology. Vol.11(2).pp.416-422, 5 January, 2012. ISSN 1684-5315 Ó 2012 Academic Journals.
    Impact Factor: 0.57

 

44. Al Jaouni, SK. Newborn screening for hemoglobin disorders and G6pd deficiency: national strategy toward a uniform screening panel and system. Journal of Applied Hematology. Vol. 3, Issue 2,  June 2012; pp 82-84.

 

45. Al Jaouni, SK., Hussein, A., Al Muhayawi, M., Ibrahim K., Elfiki, I. Honey reduces chemoradiotherapy-induced mucositis in pediatric cancer patients. Critical Reviews in Oncology Hematology 82S1(2012)pp. S17. Impact Factor: 4.637

 

46. Al Jaouni, SK., Al Muhayawi M., Halawa, T. Health and quality of life outcomes in patient with sickle cell disease. Critical Reviews in Oncology Hematology 82S1(2012)pp. S17. Impact Factor: 4.637

 

47. Al Jaouni, SK. The prevalence of the most common causes for primary thrombophilia among Saudi patients attending the anticoagulant clinic.  Critical Reviews in Oncology Hematology 82S1(2012)pp. S17-S18. Impact Factor: 4.637

 

48. Al Jaouni, SK, Al Muhayawi M., Halawa T., Al Mehayawi M. Treatment adherence and quality of life outcomes in patients with sickle cell disease. Saudi Med.J. 2013;Vol.34(3); pp.261-265. Impact Factor: 0.52

 

49. Jarullah, J., Al Jaouni, SK, Sharma, MC., Bushra, MSJ., Kamal, MA. Detection of Glucose-6-Phosphate dehydrogenase deficiency in heterozygous Saudi Female Neonates. Enzyme Engineering ;2012;1:105;Vol.1.(2);pp.1-3. Impact Factor 1.33

 

50. Ayoub MD., Radi, SA., Azab, AM., Ablaban AA., Balikhoyor AH., Bedair SW., Al Jaouni, Kari, JA. Q Quality of life among children with beta-thalassemia major treated in Western Saudi Arabia. Saudi Med.J.2013;Vol.34(12):1281-1286. Impact Factor:0.71

 

51. Jarullah, J., Al Jaouni SK., Bushra J.,  Biochemical Estimation of Glucose 6 phosphate dehydrogenase deficiency in Saudi Adults. Different methods and its rationalization. Journal Advances in Bioscience & Biotechnology., 2014, 5, 434-437. Impact Factor: 1.30 

 

52. Al Jaouni SK,  The Saudi experience on the effects of endocrine complications and its morbidity in thalassemia. IX International Workshop-ICET-A International Network of Clinicians for endocrinopathies in thalassemia and adolescence medicine. IV Pan Arab Hematology Conference. February 6, 2015.

 

53. Selim, S., Al Jaouni, SK. Anticancer, apoptotic and inhibitory effects on cell proliferation of diosgenin isolated from Costus speciosus (Koen.) Sm. Journal of BMC  Complementary and Alternative Medicine. 15:301;DOI10.1186/s12906-015-0836-8 Impact per Paper (SNIP) 0.858

 

54. Selim, S., Al Jaouni, SK. Anti-inflammatory, antioxidant and anti-Angiogenic activities of diosgenin isolated from traditional medicinal plant, Costus  speciosus (Koen ex.Retz.) Sm. Journal of Natural Product Research. July 2015. Impact Factor: 1.23. DOI:10.1080/14786419.2015.1065493. http://www.tandfonline.com/loi/gnpl20

 

55. Hamad I., AbdEgawad, H., Al Jaouni SK., Zinta, G., Asard, H., Hassan, S.,Hegab, M.,Hagagy N., Selim S. Bioactivity and metabolic analysis of various date palm fruits  (Phoenix dactylifera L.) from Saudi Arabia. Journal of Plant Food for Human Nutrition. 2015. Molecules [Impact factor 2;416]

 

56. Vincenzo DE Sanctis, Asharaf T. Soliman, Nada A. Soliman, Heba Elsedfy, Rania Elalaily, Piernicola Garofalo, Mohamed Yassin, Praveen Sobli, Saif A.H.Al Yaarubi, Shahina Daar, Yasser Wali, Bernadette Fiscina, Mohamed El Kholy  on behalf of the International Network   of Clinicians for Endocrinopathies in  Thalassemia and Adolescent Medicine (ICET-A)Al  Jaouni SK., General  principles of good transition care: A short review of the literature.   Rivista Italiana of Medicina dell Adolescenza. Suppl.1, Vol. 13,n 2,2015:pp.1-10. ISSN 20350678

 

57. Saad B. Almasaudi, Nagla A. El-Shitany, Aymn T. Abbas, Umama A. Abdel-dayem, Soad     Ali, Soad K. Al Jaouni, Steve Harakeh. Antioxidant, Anti-inflammatory, and Antiulcer potential of manuka honey agains gastric ulcer in rats. Oxidative Medicine and Cellular   Ongevity. August 2015. Impact factor 3.516.

 

58. Alaa A.M. Al-Nahari, Saad B. Almasaudi, El Sayed M. Abd El-Ghany. Elie Barbour. Soad Al Jaouni, Stever Harakeh. Antimicrobial activities of Saudi honey against Pseudomonas Aeruginosa. Saudi Journal of Biological Sciences,Vol. 22 Issue 5, Sept. 2015,pp.521-525. Impact factor :1.781

 

59. De Sanctis, V., Al Jaouni, SK., Elsedfy, H., Karimi, M., Mousa, S., Soliman, AT., El Kholy, M., Selected Highlights of the IX International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, and Endocrine Complications in Thalassemia Revista Italiana Medicina di dell' Adolescenza.

 

60. Heeney, MM., Hoppe CC., Abboud, MR., Inusa B., Kanter, J., Ogutu, B.,Brown,PB., Heath, LE., Jakubowski, JA., Zhou, C., Zamoryakhin, D.,Agbenyega, T., Colombatti, R., Hassab, HM., Nduba, VN., Oyieko JN., Robitaille, N., Segbefia, CI., Rees, DC. Supplement DOVE investigators Saudi Arabia Al  Jaouni, SK.A multinational trial of Prasugrel for sickle cells vaso-occlusive events. The New England Journal of Medicine.   DOI:10.1056.NEJMoa1512021.Dec.8,2015,pp:1-11. Impact Factor : 79.258

 

61. Ismail Hamad Hamada AbdElgawad Soad Al Jaouni, Gaurav Zinta, Han Asard, Sherif Hassan Momtaz Hegab, Nashwa Hagagy and Samy Selim  Metabolic Analysis of Various Date Palm Fruit (Phoenix dactylifera L.) Cultivars from Saudi Arabia to Assess Their Nutritional Quality Molecules 2015, 20, 13620-  13641; doi:10.3390/molecules200813620. Impact Factor : 4.064

 

62. Soad K. Al Jaouni, Steve Biological Activity of Cymbopogon  schoenanthus     Essential Oil. Saudi Journal of Biological Sciences. Ms. Ref. No.: SJBS-D-16-00381R1. Impact Factor: 3.244

 

63. Vincenzo De Sanctis, Ashraf T. Soliman, Heba Elsedfy, Alice Albu, Soad Al Jaouni, Saif Al Yaarubi, Salvatore Anastasi, Duran Canatan, Massimo Di Maio, Salvatore Di Maio, Mohamed El Kholy, Mehran Karimi, Doaa Khater, Yurdanur Kilinc, Su ha Lum, Nicos Skordis, Praveen Sobti, Iva Stoeva, Ploutarchos Tzoulis, Yasser Wali and Christos Kattamis. The ICET-a survey on current criteria used by clinicians for the assessment of central adrenal insufficiency in thalassemia: analysis of results and recommendations". Mediterranean Journal of Hematology and Infectious Diseases. www.mjhid.orig 2016;8;e2016034.pp.1-9. Impact Factor: 1.183

 

64. Ishani Shah, Jummanah Jarullah, Soad K. Al Jaouni. Mohammad Sarwar Jamal, Bushra Jarullah. Higher prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in tribal population against urban population : A signal to natural selection. Biomedical Research 2017;28(1) June 07, 2016 pp. 1-4. Ref.:  Ms. No. Allied Academies-16-351R1.  ISSN 0970-938X.  Impact Factor : 0.219

 

65. Samiha A. Mourad & Soad K. Al Jaouni. The Effect of Wet Cupping on Blood Haemoglobin Level. Alternative & Integrative Medicine.ISSN:2327-5162 AIM, Vol. 5.Issue2.1000217.  Impact Factor: 0.78

 

66. Gasal M. Hashim, Saad B. Almasaudi, Esam Azhar, Soad K. Al Jaouni, Steve Harakeh. Biological activity of Cymbopogon schoenanthus essential oil. Saudi Journal of Biological Sciences. 2016.06.001;pp.1-7. Impact Factor: 3.138

 

67. Muhammad Sheraz Arshad Malik, Soad K. Al Jaouni, Steve M. Harakeh & Mohammad Faraz Arshad Malik. Therapeutic implications of Nigella Sativa against cancer metastasis. Pak.J.Pharm.Sci.Vol. No. 5 (Suppl), September 2016, pp.1881-1884.  Impact Factor 1.103

 

68. Ali Hafez El-Far, Hazem Mohammed Shaheen, Mohamed M. Abdel-Daim, Soad K. Al Jaouni & Shaker A. Mousa. Date Palm (Phoenix dactylifera): Protection and Remedy Food. iMedPub Journals.July 27, 2016;Vol.1.No.2:9;pp:1-10.

 

69. Vincenzo De Sanctis, Ashraf T. Soliman, Heba Elsedfy, Alice Albu, Soad Al Jaouni, Salvatore Anastasi, Maria Grazia Bisconte, Duran Canata, Soteroula Christou, Shahina Daar, Salvatore Di Maio, Mohamed El Kholy, Doaa Khater, Mohamed Elshinawy, Yurdanur Kiline, Roberto Mattei, Hala H. Mosli, Alessandra Quota, Maria Grazia Roberti, Praveen Sobti, Saif Al Yaarubi, Saveria Canpisi and Christos Kattamis. Review and recommendations on management of adult female thalassemia patients with hypogonadism based on literature review and experience of ICET-A network specialists. Medterr J Hematol Infect Dis 2016;8;e2016058:pp.1-10. Impact Factor: 1.183

 

70. . Soad Al Jaouni,Eman A. Elfiky, Samiha A. Mourad, Nahla Khamis Ibrahim, Abdullah M. Kaki, Sawsan M. Rohaiem, Mohamad H. Qari, Laila M. Tabsh, Adel M. Aljawhari. The effect of wet cupping on quality of life of adult patients with chronic medical condition in King Abdulaziz University Hospital. Saudi Med. J 2017;Vol. 38(1) pp.179-189.Impact Factor: 1.055

 

71. S. Selim Abdel Salam, Soad Al Jaouni. Vitamin E (α-tocopherol) contents and antimutagenicity potentials Talbina (Hordeum vulgare L.). The FEBS Journal 283 (Suppl.1)2016 129-417 DOI:10.1111/febs.13808. Impact Factor: 4.530

 

72. Vicenzo De Sanctis, Ashraf T. Soliman, Heba Elsedfy, Said Al Yaarubi, Nicos Skordis, Doaa Khater, Mohamed El Kholy, Iva Stoeva, Bernadette Fiscina, Michael Angastiniotis, Shahina Daar and Crhistos Kattamis. On behalf of ICET-A participants: Soad Al Jaouni. The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose homoestasis in thalassemia Major patients . Mediterr J Hematol Infect Dis 2016, 8(1):e2016058. pp.2-14. Impact Factor: 1.183

 

73. Soad K. Al Jaouni, Eman A. ElFiky, Samiha A. Mourad, Nahla K. Ibrahim, Abdullah M. Kaki, Sawsan M. Rohaiem, Mohamad H. Qari, Laila M. Tabsh, Adel A. Aljaehari. The effect of wet cupping on quality of life of adult patients with chronic medical conditions in King Abdulaziz University Hospital. Saud Med J 2017;Vol.38(1)pp.53-62. Impact Factor: 1.055

 

74. Saad B. Almasaudi, Aymn T. Abbas, Rashad R. Al-Hindi, Nagla A. El-shitany, Umama A. Abdel-dayem, Soad S. Ali, Rasha M. Saleh, Soad K. Al Jaouni, Mohammad Amjad Kamal and Steve Harakeh. Manuka Honey Exerts Antioxidant and Anti-Inflammatory Activities that Promote Healing of Acetic Acid-Induced Gastric Ulcer in Rats.  Evidence-Based Complementary and Alternative Medicine Vol. 2017 (2017), Article ID 5413917, 12 pages. https://doi.org/10.1155/2017/5413917. Impact Factor: 1.931

 

75. Vincenzo De Sanctis, Christos Kattamis, Duran Canatan, Ashraf T. Soliman , Heba Elsedfy, Mehran Karimi, Shahina Daar, Yasser Wali, Mohamed Yassin, Nada Soliman,  Praveen Sobti, Soad Al Jaouni, Mohamed El Kholy, Bernadette Fiscina, Michael Angastiniotis. β- thalassemia distribution in the old  world: an historical standpoint of   an ancient disease   Seen from a historical standpoint. Mediterranean Journal of Hematology and Infectious   Diseases 2017;9;e2017018;pp.1-14.  Impact Factor: 1.183

 

76. Ismail Hamad, Hamada Abd Elgawad, Soad Al Jaouni, Gaurav Zinta, Han Asard, Sherif Hassan, Momtaz Hegab, Nashwa Hagagy and Samy Selim. 2015. Nutritional and functional properties of dates: A review. Crit Rev Food Sci Nutr.,48 (10),pp:877-87.24. Impact Factor: 6.077

 

77. Soad K. Al Jaouni, Mohammad S. Al Muhayawi, Abear Hussein, Iman Elfiki, Rajaa Al- Raddadi, Saad M. Al Muhayawi, Saad Almasaudi, Mohammad Amjad Kamal and Steve Harakeh. Effects of Honey on oral mucositis among Pediatric cancer patients undergoing chemo/radiotherapy treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia. Hindawi Publishing Corporation. Evidenced-Based Complementary and    Alternative Medicine Vol. 2017, Article 5861024;pp:1-7. http://doi.org/10.1155/2017/5861024 ,
Impact Factor: 2.064

 

78. Mustafa S. Atta I, Essam A. Almadaly, Ali H. El-Far, Rasha M. Saleh, Doaa H.Assar, Soad K. Al Jaouni and Shaker Mousa, Thymoquinone Defeats Diabetes- Induced Testicular Damage in Rats Targeting Antioxidant, Inflammatory and Aromatase Expression, Int. J. Mol. Sci. 2017, 18(5), doi:10.3390/ijms18050919
Impact Factor 3.257.

 

79. Soad K. Al Jaouni, The Saudi experience on the effects of endocrine complications and its morbidity in thalassemia and the role of collaboration with international network of clinicians for endocrinopathies in thalassemia and adolescent medicine (ICET-A). Journal of Blood Disorders & Transfusion May 2017,Vol. 8,Issue 2;ISSN:2155-9864.p.26.
Impact Factor:  1.27

 

80. Soad K. Al Jaouni, Nigella sativa and honey improves quality of life in Kostmann syndrome: Case report. Journal of Blood Disorders & Transfusion May 2017,Vol. 8,Issue 2;ISSN:2155-9864.p.48.
Impact Factor:  1.27

 

81. Soad K. Al Jaouni, Hydroxyurea, an effective therapy to avoid splenectomy in sickle cell disease and thalassemia: Single institute experience in Saudi Arabia. Journal of Blood Disorders & Transfusion May 2017,Vol. 8,Issue 2;ISSN:2155-  9864.p.32.
Impact Factor:1.27

 

82. Steve Harakeh. Josiane Semaan, Marwan El Sabban, Soad K. Al Jaouni, Mona Diab-Assaf and Rania Azar. Thymoquinone inhibits proliferation and induces apoptosis in leukemic cells. Molecular and Cellular Biology, Genetics July 2017, Vol.77; Issue 13 Supplement.DOI:10.1158/1538-7445.AM2017-4300.
Impact Factor: 3.813

 

83. Rashad R. Al-Hindi, Soher E. Ely, Amal S. Hathout, Mona G. Alharbi, Saad Al- Masaudi, Soad K. Al-Jaouni, Steve M. Harakeh. Isolation and molecular characterization of mycotoxigenic fungi in agarwood. Saudi Journal of Biological Sciences Impact Factor: 3.138  (2017),doi:http://dx.doi.org/10.1016/j.sjbs.2017.07.008

 

84. S. Selim Abdel Salam, Soad Al Jaouni, Antimicrobial and timutagenicity potentials of Hordeum vulgare L. extract. Bioscience Research, 2017 volume 14(2):139-142. Impact Factor (Scopus) 2017 : 0.737

 

85. Rahaf Mohamad Qari, Soad Al Jaouni. Congenital bilateral radioulnar synostosis with acute Lymphoblastic leukemia: A case report. Journal of Applied Hematology, 2017;8:36-8.

 

86. Soad Al Jaouni, Taher Halawa, Abear Hussein, Salwa Al Najjar, Mohammad S.Almuhayawi, Steve Harakeh. Nigella sativa and Saudi honey diminish infections and improve the survival in a Kostmann's Syndrome patient: Case report. J Appl Hematolgy 2017July- September; Vol.8; Issue 3:119-112.

 

87. Soad K. Al Jaouni , Sahd Naghi,Quality of life improve by Nutrition in Sickle cell Disease,6th Pan Arab Hematology Congress , Kuwait 11-13 February2017.

 

88. Harakeh S, Khan I, Almasaudi SB, Azhar EI, Al-Jaouni S, Niedzweicki A. Role of Nutrients and Phyto-compounds in the Modulation of Antimicrobial Resistance. Curr Drug Metab. 2017 Jul 18. Doi: 10.2174/1389200218666170719095344. Impact Factor: 2.972

 

89. Steve Harakeh, Josiane Semaan, Marwan El-Sabban, Soad K. Al Jaouni, Rania Azar, Mona Diab-Assaf Thymoquinone Inhibits Proliferation and induces apoptosis in leukemic cells. Annual Meeting of 110 American Associations for Cancer Research (AACR) Washington D.C. 1-5 April, 2017. DOI: 10.1158/1538-7445.AM2017-4300 Published July 2017.

 

90. Assaf MD, Semaan J, El-Sabban M, Al-Jaouni SK, Azar R, Kamal MA, Harakeh S. Inhibition of proliferation and induction of Apoptosis by Thymoquinone via modulation of TGF family, p53, p21 and Bcl-2α in leukemic cells. Anticancer Agents Med Chem. 2017 Sep 12. doi: 10.2174/1871520617666170912133054. Impact factor: 2.556

 

91. Rashad R. Al- Hindi, Soher E. Aly, Amal S. Hathout, Saad Al-Masaudi Soad K. Al-Jaouni,and Steve M. Harakeh. Isolation and molecular characterization of mycotoxigenic fungi in& Agarwood. Accepted in Saudi Biological Sciences. Impact Factor: 3.138

 

92. Alexandra de Sousa, Hamada AbdElgawad, Asard Han, Ana Pinto, Cristiano Soares, Simão Branco-Neves, Teresa Braga, Manuel Azenha, Samy Selim,Soad Al Jaouni, Fernanda Fidalgo and Jorge Teixeira (2017). Metalaxyl Effects on Antioxidant Defenses in Leaves and Roots of Solanum nigrum L. Front. Plant Sci. 8:1967.doi:10.3389/fpls.2017.01967Impact factor: 4.298

 

93. Hany Elgohary, Soad Al Jaouni and Samy Selim (2017). Wound healing: In response to natural remedies and phototherapy. International Journal of Research in Pharmaceutical Sciences, 8(4), 1-8. Impact factor: 0.24

 

94. Assaf MD, Semaan J, El-Sabban M, Al-Jaouni SK, Azar R, Kamal MA, Harakeh S. Inhibition of proliferation and induction of Apoptosis by Thymoquinone via modulation of TGF family, p53, p21 and Bcl-2α in leukemic cells. Anticancer Agents Med Chem. 2017 Sep 12. doi: 10.2174/1871520617666170912133054. Impact factor: 2.556

 

95. Harakeh S, Khalife J, Baydoun E, Azar R, Al-Hejin A, Barbour E, Azhar E, Niedzwiecki A, Al Jaouni S, Diab-Assaf M, Kamal MA, Rath M. Effects of Ascorbic Acid on Tax, NF- κB and MMP-9 in Human T-cell Lymphotropic virus type 1 positive malignant T-Lymphocytes. Anticancer Agents Med Chem. 2017 Jul 25. doi: 10.2174/1871520617666170725160628. Impact factor: 2.556

 

96. Harakeh S, Khan I, Almasaudi SB, Azhar EI, Al-Jaouni S, Niedzweicki A. Role of Nutrients and Phyto-compounds in the Modulation of Antimicrobial Resistance. Curr Drug Metab. 2017 Jul 18. Doi: 10.2174/1389200218666170719095344. Impact factor: 2.655

 

97. Vincenzo De Sanctis, Ashraf T. Soliman, Duran Canatan, Heba Elsedfy, Mehran Karimi, Shahina Daar, Hala Rimawi, Soteroula Christou, Nicos Skordis, Ploutarchos Tzoulis, Praveen Sobti, Shruti Kakkar, Yurdanur Kilinc, Doaa Khater, Saif A Alyaarubi, Valeriya Kaleva, Su Han Lum, Mohamed A Yassin, Forough Saki, Maha Obiedat, Salvatore Anastasi, Maria Concetta Galati, Giuseppe Raiola, Saveria Campisi, Nada Soliman, Mohamed Elshinawy, Soad Al Jaouni, Salvatore Di Maio,Yasser Wali, Ihab Zaki Elhakim, Christos Kattamis. An ICET- A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report. Acta Biomed 2017; Vol. 88, N. 4: 435-444 DOI: 10.23750/abm.v88i4.6837.

 

98. Mona Diab-Assaf, Josiane Semaan, Marwan El-Sabban, Soad Al Jaouni Amjad Kamal and Steve Harakeh. Inhibition of Proliferation and Induction of Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells. Anti-Cancer Agents in Medicinal Chemistry J. Ref. No. ACAMC-18-19820. 23th International Scientific Conference Of Laas, Lebanon 6-7 April, 2017

 

99. Soad Al Jaouni, Ahmed M. Saleh2,3, Mohammed A.M. Wadaan4, Wael N. Hozzein4, Samy Selim5,6 Hamada AbdElgawad7,8, Elevated C02 induces a global metabolic change in basil (Ocimum basilicum L.,) and peppermint (Mentha piperita L.) and improves their biological activities, plant physiology Impact factor: 3.121,2018.

 

100. Ali Hafez El-Far, Hazem M. Shaheen, Abdel Wahab Alsenosy, Yasser S.El-Sayed, Soad K. Al Jaouni, Shaker Mousa, Costus speciosus: Traditional Uses, Phytochemistry, and Therapeutic Potentials, Journal of Pharmacognosy & Natural Products, Impact Factor: 1.279

 

101. Samy Selim, Soad Al Jaouni, Hussian Mohamed, Hamada AbdElgawad In vitro Assessment of Bioactivity Potentials of β-D-glucogallin Extracted from  Ajwah Date Palm (Phoenix dactylifera L.) Pits. International Conference on Biological, Environmental Sciences & Applications (ICBESA-2018) 25-28 August 2018, Hurghada, Egypt.

 

102. El-Far AH., Oyinloye BE., Sepehrimanesh M., Allah MAG, Reidah IA., Shaheen HM., Razeghian-Jahromi I.,Alsenosy AEA., Al Jaouni SK., Mousa SA. Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery. Curr Drug Discovery Technol, 2018 March 19. doi:10.2174/1570163815666180320111937.

 

103. Luisa Mota da Silva, Priscila de Souza, Soad K, Al Jaouni, Steve Harakeh, Shahram Golbabapour and Sergio Faloni de Andrade. Propolis and it's potential to treat gastrointerstinal disorders. Evidence -Based Complementary and Alternative Medicine. Vol. 2018,Article ID 2035820,pp.1- 12;doi.org/10.1155/2018/2035820. Impact Factor: 1.931

 

104. Soad Al Jaouni, Ahmed M. Saleh, Mohammed A.M. Wadaan, Wael N. Hozzein, Samy Selim, Hamada Abdelgawad. Elevated CO₂ induces a global metabolic change in basil (Ocimum basilicum L.) and peppermint (Mentha piperita L.) and improves their biological activity. Journal of Plant Physiology. March 05, 2018. https://doi.org/10.1016/j.jplph.2018.03.016. impact factor 121

 

105. Ali H. El-Far, Babatunji Emmanuel Oyinloye, Masood Sepehrimanesh, Mahmoud A. Gab Allah, Ibrahim AbuReidah, Hazem M. Shaheen, Iman Razeghian-Jahromi, Abd El-wahab A. Alsenosy, Ahmed E. Noreldin, Soad K. Al Jaouni and Shaker A. Mousa. Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery. Journal Current Drug Discovery Technologies. Reference No: CDDT-18-20396. ISSN: 1875-6220

 

106. Ali Hafez El-Far, Hazem M. Shaheen, Abdel Wahab Alsenosy, Yasser S. El-Sayed, Soad Al Jaouni, Shaker A. Mousa. Costus speciosus: Traditional Uses, Phytochemistry, and Therapeutic Potentials. Pharmacognosy Reviews Vol.12;Issue 23;January-June 2018.ISSN: 0973-7847;pp:120-127 Impact Factor: 6.25

 

107. Mohamed Lebda, Ali El-Far, Ahmed Nor Eldein, Yaser Elewa, Soad Al Jaouni and Shaker Mousa. Protective Effects of Miswak (Salvadora persica) Against Experimentally induced Gastric Ulcers in Rats. Oxidative Medicine and Cellular Longevity. Article ID 6703296. Impact Factor: 936

 

108. Mustafa S. Atta, Ali H. El-Far, Foad A. Farrag, Mohamed M. Abdel-Daim, Soad K. Al  Jaouni, Shaker A. Mousa. Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats  Oxidative Medicine and Cellular Longevity
     Volume 2018, Article ID 7845681, 10 pages ,https://doi.org/10.1155/2018/7845681, Impact Factor: 4.936 

 

109. Thikryat A Neamatallaha, Nagla A El-Shitanya, b, Aymn T Abbasc, d, SoadS Alie, Basma G Eida … Dayem, SS Ali, RM Saleh, SK Al Jaouni, MA Kamal and SM …Honey protects against cisplatin-induced hepatic and renal toxicity through inhibition of NF-kB-mediated COX-2 expression and oxidative stress dependent BAX/Bcl-2/caspase-3 apoptotic pathway. Food & Function, May 2018: DOI.10.1039/C8FO00653A. Impact Factor:8

 

110. Luisa Mota da Silva, Priscila de Souza, Soad K. Al Jaouni, Steve Harakeh, Shahram Golbsbapour & Sergio Faloni de Andrade. Propolis and Its Potential to Treat Gastrointestinal Disorders. Evidence-Based Complementary and Alternative Medicine; Vol. 2018, Article ID 2035820, 12 pages https://doi.org/10.1155/2018/2035820.
Impact Factor: 1.931

 

111. Steve Harakeh, Soad Al Jaouni, Soad Ali, Huda Abuaraki, Saad Almasaudi. Effects of Saudi Honey on Gastric Ulcers in Rats. International Conference on Gastroenterology & Digestive Disorders. May 14-16, 2018, Melbourne Parkview Hotel, Australia.

 

112. Ibrahim A. Alotibi, Steve M. Harakeh, Mohammed Al-Mamary, Abdalbasit A. Mariod, Soad K. Al Jaouni, Saad Al-Masaud, Mona G. Alharbi, Rashad R. Al-Hindi. Floral Markers and Biological Activity of Saudi Honey, Saudi Journal of Biological Sciences (2018), doi: https://doi.org/10.1016/j.sjbs.2018.05.021. Impact Factor: 3.138

 

113. Hany M. Elgohary, Soad K. Al Jaouni and Samy A. Selim. Effect of ultrasound-enhanced Nigella sativa seeds oil on wound healing: An animal model. Journal of Taibah University Medical Sciences461 June 26, 2018;pp.1-6.

 

114. Mohamed A. Lebda , Ali H. El-Far , Ahmed E. Noreldin , Yaser H. A. Elewa Soad K. Al Jaouni, and Shaker A. Mousa , Protective Effects of Miswak (Salvadora persica) against Experimentally Induced Gastric Ulcers in Rats, Oxidative Medicine and Cellular Longevity, Accepted 24 May 2018,Impact Factor 4.936

 

115. Shahad Naghi , Soad K. Al Jaouni , Abear Hussein,Abdulgalil Abdulkadeer, Camel milk is good nutrition and decreased the risk of thrombosis in pediatric Hematology/Oncology patients at King Abdulaziz University Hospital , King  Abdulaziz University, Jeddah : Cohort study over 10 years . 16^th Annual Metting of Saudi Society of Hematology & VII Pan Arab Hematology  Association Congress, 24-25 Feb.2018 Jeddah. 

 

116. Shahad Naghi , Soad K. Al Jaouni , Mutasem Al Mehayawi, Honey improves the quality of life outcomes and decreased the painful crisis in sickle cell disease .16th Annual Metting of Saudi Society of Hematology VII Pan Arab Hematology Association Congress, 24-25 Feb.2018 Jeddah.

 

117. Maged S. Bin Masalam, Ahmed Bahieldin,1 Mona G. Alharbi,1 Saad Al- Masaudi, Soad Al-Jaouni, Steve M. Harakeh , and Rashad R. Al-Hindi,Isolation, Molecular Characterization and Probiotic Potential of Lactic Acid Bacteria in Saudi Raw and Fermented Milk, Evidence-Based Complementary and Alternative Medicine , Volume 2018, Article ID 7970463, 12 pages. Impact Factor: 1.931

 

118. Soad K. Al Jaouni , Effects Of Wet Cupping Therapy On The Quality Of Life Of Adult Patients with Chronic Diseases in King Abdulaziz University: Single Institute Experience from Saudi Arabia, International Conference on  Alternative and Traditional Medicine,July 23-25, 2018 Rome, Italy.

 

119. Soad K. Al Jaouni, Effect of Phoenix dactylifera Palm fruit (Ajwa) on Infection,Hospitalization,  Mortality, Safety and Quality of life among Pediatric Cancer Patients at King Abdulaziz University Hospital in the Kingdom of Saudi Arabia, 12th World Hematologists Congress March 15-16, 2018 London, UK

 

120. Fawzia Alzahrani, Siham Abunasef, Soad Ali, Nouf Al-Abbas, Nehad Shaer Soad Al Jaouni , Gamal Karrouf, Steve Harakeh, Ethanolic Extracts of Ficus carica and Olea europaea for Wound Treatment in   Adult Rabbits,  Molecules 2018. In Press.

 

121. Soad K. Al Jaouni, Mohammad S. Almuhayawi, Abear Hussein, Steve Harakeh, Saad M.l Muhayawi , The effect and safety of saudi honey as antioxidant among pediatric Cancer patients: randomized clinical trials at single Medical institute in the kingdom of Saudi Arabia ,September 19- 20, 2018 International Colloquium on Oncology & Cancer Research Conference in Dubai, UAE.

 

122. Badr Madani; Rajaa Al Raddadi; Soad Al Jaouni; Mohab Omer; Marie-Isabelle Al Awa, Quality of life among caregivers of sickle cell disease patients: A cross sectional study" (HQLO-D-18-00037R2) Health and Quality of Life Outcomes. BMC, (2018) 16:176. https://doi.org/10.1186/s12955-018-1009-5. Impact Factor 7.98

 

123. Ahmed M. Saleh, Samy Selim, Soad Al Jaouni, Hamada AbdElgawad. CO₂ enrichment can enhance the nutritional and health benefits of parsley (Petroselinum crispum L.) and dill (Anethum gravelens L.) Journal of Food Chemistry  269 (2018) 519-526. Impact Factor: 4.610.

 

124. Ali El-Far, Soad K. Al Jaouni, Weikun Li, Shaker A. Mousa. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases. Nutrients 2018, 10, 1369; doi:10.3390/nu10101369 Impact Factoris 4.196.

 

125. Mustafa S. Atta, Ali H. El-Far, Foad A. Farrag, Mohammed M. Abdel-Daim, Soad K. Al Jaouni and Shaker Moussa. Thymoquinone Attenuates Cardiomyopathy in treptozotocin-treated diabetic rats. Hindawi Oxidative Medicine and Cellular Longevity 2018. Article ID In Press. Impact Factor:4.936

 

126. Vincenzo De Sanctis, Ashraf T. Soliman, Duran Canatan, Ploutarchos Tzoulis,Shahina Daar, Salvatore Di Maio, Heba Elsedfy, Mohamed A. Yassin, Aldo Filosa, Nada soliman, Mehran Karimi, Forough Saki, Praveen Sobti, Shruti Kakkar, Soteroula Christou, Alice Albu, Constantinos Christodoulides, Yurdanur Kilinc, Soad K. Al Jaouni, Doaa Khater,Saif A. Alyaarubi, Su Han  Lum, Saveria Cmpisi, Salvatore Anastasi, Maria Concetta Galati, Giuseppe Raiola, Yasser Wali, Ihab Z. Elhakim, Demetris Mariannis, Vassilis Ladis, Christos Kattamis. An ICET-A survey on occult and emerging endocrine
     complications in patients with B-thalassemia major: Conclusions and  recommendations. Acta BiomedicaScientia,2018: Vol.89,N.4:481-489.  DOI:10.23750/abm.v89i4.7774. eISSN: 2348-215X , Mattioli 1885 Journals

 

127. Steve Harakeh, Josiane Semaan, Marwan El-Sabban, Soad K. Al Jaouni, Rania Azar, Mona Diab-Assaf , Thymoquinone Inhibits Proliferation and  induces apoptosis in leukemic cells, First International Conference on Nanotechnology: Theory and Applications NTAconf , Cairo, Egypt, 10 - 13  December 2018.

 

128. Ahlem Zrig, Jorge F.S. Ferreira, Foued Hamouda, Taieb Tounekti, Samy Selim, Soad Al Jaouni, Habib Khemira & Hamada Abdelgawad. The impact of foliar fertilizers on growth and biochemical responses of Thymus vulgaris to salinity stress. Arid Land Research and Management. January 12, 2019.  DOI:10.1080/15324982.2018.1551817. Impact Factor. 0.970.

 

129. Soad K. Al Jaouni, 17th Annual Meeting of Saudi Society of Hematology & 8th Pan Arab Hematology Association Congress, Le Meridien Madinah, February 1-3, 2019.

 

130. Soad K. Al Jaouni, Control the disease Complication of Thalassaemia Major improve the Survival & Quality of life: the Saudi experience on the endocrine complications and its morbidity. Hematology and Blood Transfusion Conference 7th Medlab Congress, February 2019 at Dubai, UAE CME 33

 

131. Soad K. Al Jaouni et al, "Effects of Phoenix dactylifera Ajwa on Infection, Hospitalization, and Survival Among Pediatric Cancer Patients in a University Hospital: A Non-randomized Controlled Trial Integrative Cancer Therapies, Vol. 18(1):1- 9.DOI:10.1177/1534735419828834. impact factoris :2.657

 

132. Nouf Al-Abbas, Professor Soad Al Jaouni, Dr Mona Atia, Professor Soad Ali Ali, El-Mokhtar Ahmed, Dr Fawzia Alzahrani. Can Fig and  Olive Ameliorate The Toxicity Induced by 2-nitropropane In Some Organs  Of Mice? Role Of Inflammatory Versus Anti-inflammatory Genes. Experimental and Molecular Pathology.

 

133. Soad Al Jaouni, Effects of Wet cupping on the Quality of Life of Adult Patients with Chronic Diseases Experience of King Adbulaziz University Hospital over 6 years. Novel therapy for refractory iron chelation for thalassemia patients with liver iron overload: Case series Natural products can improve the quality of life in Pediatric Hematology/Oncology patients: Controlled studies from King Abdulaziz University Hospital. Holistic approach to improve Healthcare, February 4-6, 2019, Rotana Beach Hotel -Al Thuraya Hall-Abu Dhabi. Lotus Presents In Collaboration with Family Medicine Residency Program.

 

134. Soad Al Jaouni, Disease controlled of Thalassemia improved the survival and quality of life : 28 years' experience from King Abdulaziz University Hospital, MedLab Congress Conventional Center Dubai February 4-7, 2019.CME 33 Cleveland Clinics

 

135. Steve Harakeh, Imran Khan, Saad B. Almasaudi, Esam I. Azhar, Soad Al- Jaouni and Aleksandra Niedzweicki. Role of Nutrients and Phyto- compounds in the Modulation of Antimicrobial Resistance. Current Drug Metabolism, 2017, Vol. 18, No.00 Impact Factor: 2.74

 

136. Mona Diab-Assaf, Josiane Semaan, Marwan El-Sabban, Soad K. Al Jaouni Rania Azar, Mohammad Amjad Kamal and Steve Harakeh. Inhibition of Proliferation and Induction ofDetecting Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells. Anti- Cancer Agents in Medicinal Chemistry, 2018, 18,210-215. . Impact Factor: 2.556

 

137. Soad Al Jaouni , Seham Abdulhadi, Majda Hagras, Dr. Hani Elbasosi, Dr. Numan Abdullah , Participated with 2 oral presentations First International Conference on Nanotechnology Theory and Applications, December  2018, Cairo, Egypt The Effect of Ajwa Nano-Preparation on Ischemic Heart Disease
     استخدام تقنية النانو بالعجوة لعلاج الذبحة الصدرية
     The Effect of Ajwa Nano-Preparation to treat chemotherapy  (Adrimycin )  induced cardiomyopathy
     استخدام تقنية النانو بالعجوة لعلاج تأثير العلاج الكيميائي أدرمايسن على القلب

 

138. Hamada AbdElgawad, Ahmed M. Saleh, Soad Al Jaouni, Samy Selim, Mahmoud O. Hassa, Mohammed A.M. Wadaan, Ahmed M. Shuika, Hussein S. Mohamed, Wael N. Hozzein. Utilization of actinobacteria to enhance the production and quality of date palm (Phoenix dactylifera L.) fruits in a semi- arid environment. Science of the Total Environment 665 (2019) 690-697. Impact Factor: 4.610.

 

139. Abdullah Kaki, Rohaiem Sawsan, Mourad Samiha, Soad Al Jaouni, Mohsen Abdul Elalah and Nahla Ibrahim. Wet Cupping reduces pain and improves health-related quality of life among patients with migraine: A prospective observational study. Oman Medical Journal (2019), Vol. 14, No.2: 105-109. Impact Factor 0.28

 

140. Soad K. Al Jaouni, Samy Selim, Sherif H. Hassan, Hussein S.H. Mohamad and Hamada Abdelgawad. Vermicompost supply modified chemical composition and improved nutritive and medicinal potentials of date palm fruits from Saudi Arabia. Original Research, Frontiers in Plant Science Crop and Product Physiology 11April 2019.  Manuscript ID: 362438. Impact Factor 4.298   frontiers.org

 

141. Ali H. El-Far, Babatunji E. Oyinloye, Masood Sepehrimanesh, Mahmoud A. Gab Allah, Ibrahim Abu-Reidah, Hazem M. Shaheen, Iman Razeghian-Jahromi, Abd el- wahab A.  Alsenosy, Ahmed E. Noreldin, Soad K. Al Jaouni and Shaker A. Mousa. Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery, Current Drug Discovery Technologies, 2019, Vol. 16,

 

142. Lamya Baharith, Samiha Murad, Soad K. Al Jaouni. Effect of wet cupping on patients with vitamin D deficiency in King Abdulaziz University Hospital, Journal of King Abdulaziz University-Medical Sciences. In Press.

 

143. Ali H. El-Far; Soad K. Al Jaouni; Shaker A. Mousa, Thymoquinone- chemotherapeutic agents combinations: Anticancer potentiation, toxicity alleviation, and future recommendations, In Press

 

144. Abdel-wahab A. Alsenosy, Ali H. El-Far, Safinaz A. Ibrahim, Kadry M. Sadek, Mustafa S. Atta, Ahmed Sayed-Ahmed, Soad K. Al Jaouni, and Shaker A. Mousa, Graviola (Annona muricata) attenuates behavioural and  testicular alterations induced by streptozotocin in diabetic rats, In Press

 

145. Ali El-Far, Shaker Mousa, Soad K. Al Jaouni, Mohamed Tantawy. Thymoquinone-Chemotherapeutic Combinations: Improved Anticancer Efficacy and Safety. In Press.

 

146. Fatma Al-Harbi, Mohamed Abo-Golaye, Othman Baothman, Mazin Zamzami, Hoda Abo Gabal, Nouf Al-Abbas, Nehad Shaer, Soad Al Jaouni, Gamal Karrouf, Shaker A. Mousa, Steve Harakeh. Osteogenic effects of garden cress (Lepidium Sativum) seed on induced fracture healing in rabbits. Pakistan Journal of Pharmaceutical Sciences. In Press.

 

147. Lamya A. Baharith, Samiha A. Mourad, Hanan M. Alghamdi, Soad K. AL Jaouni, The Effect of wet Cupping Therapy on reducing bone pain for patients in King Abdulaziz   University Hospital: A Retrospective study, SMJ In Press.

 

 

148. Soad K. Al Jaouni, Seham Abdul-Hady, Hany El-Bassossy, Numan Salah, Magda Hagras. Ajwa Nano-Preparation prevents Doxorubicin associated cardiac dysfunction: Effect on cardiac ischemia and antioxidant capacity. In Press,

 

149. Dr Ali El-Far , Dr Shaker Mousa, Dr Mohamed Tantawy, Soad K. Al Jaouni, Thymoquinone-Chemotherapeutic Combinations: Targeting Cancer Stem Cells as New Regimen to Combat Cancer, In Press

 

150. Soad K. Al Jaouni, 24th European Hematology Association Congress, June 14- 16, 2019, Amsterdam Netherlands. Participated with 3 oral presentations: Hydroxyurea an effective therapy to avoid splenectomy in sickle cells disease and thalassemia:15 years experience in Saudi Arabia) Effects of Ajwa on Disease Complications and Cardiac Among Hematological Malignancy and Ajwa: Nanoformulations on The Anti- Cancer and Safety The Efficacy of Tranexamic Acid in minor surgery and Dental work with Bleeding Disorders patients over 17 years: Single institute experience at King Abdulaziz University Hospital at the Kingdom of Saudi Arabia.

 

151. T.M. Elgemmezi, M. Badawi, F. Azher, M. Bayuomi, S. Hindawi, Soad K. Al Jaouni. Transfusion management of a sickle cell disease patient with multiple allo-antibodies. 29th Regional Congress of the ISBT 2019, IN conjunction with Swiss Transfusion SRC and the Swiss Association for Transfusion Medicine to be held in Basel, Switzerland from June 22 to 26 2019

 

152. Elham Abdallah , Nouf Al-Abbas, Mona Atia, Fawzia Alzahrani, El-Mokhtar Ahmed, Soad Ali Ali, Soad Al Jaouni, Can Fig and Olive Ameliorate The Toxicity Induced by 2- nitropropane In Some Organs Of Mice? Role Of Inflammatory Versus Anti- inflammatory Genes , In Press

 

153. Khalid Hakeem, Mohammed S. Al Muhayawi, Shaker Mousa, Steve Harakeh, Soad Al Jaouni, Wafaa Ramadan, Effects of pomegranate and ellagic acid on the histopathological hallmarks of Alzheimer’s disease in the hippocampus of aluminum chloride induced rat model, In Press.

 

154. Ezzudin Ahmad Okmi, Rajaa M. Al-Radaddi, Soad K. Al Jaouni, The Effect of Wet cupping on chronic pain in King Abdulaziz University Hospital, 2017: A retrospective record review study.

 

155. Prof. Soad Al Jaouni, MD, FRCPC, Prof. Seham Abdulhadi, Prof. Majda Hagras, Dr. Hani Elbasosi, Dr. Numan Abdullah Method of Treating Ischemic Heart Disease US9,861,675B1, Jaun 9, 2018

 

156. Soad K. Al Jaouni, 24th European Hematology Association Congress, June 14-16, 2019, Amsterdam Netherlands. Participated with 3 abstracts:

 

157. T.M. Elgemmezi, M. Badawi, F. Azher, M. Bayuomi, S. Hindawi, Soad K. Al Jaouni. Transfusion management of a sickle cell disease patient with multiple allo-antibodies. 29th Regional Congress of the ISBT 2019, IN conjunction with Swiss Transfusion SRC and the Swiss Association for Transfusion Medicine to be held in Basel, Switzerland from June 22 to 26 2019.

 

158. Vincenzo De Sanctis, Ashraf T. Soliman , Shahina Daar, Heba Elsedfy, Salvatore Di Maio, Mohamed Yassin, Ihab El-Hakim, Antonis Kattamis, Vassilis Ladis , Duran Canatan , Joan-Lluis Vives Corrons, Demetris Mariannis, Soteroula Christou , Mehran Karimi, Nada Soliman, Soad Al Jaouni , Dulani Kottahachchi, Shruti Kakkar, Maria Concetta Galati, Giuseppe Raiola, Saveria Campisi , Christos Kattamis, Detecting Glucose Related Disturbances in Patients with Transfusion Dependent Thalassemia (TDT): From old to new concepts, Rivista Italiana di Medicina dell’Adolescenza - Volume 17, n. 2, 2019

 

159. . Soad K. Al Jaouni, Seham Abdul-Hady, Hany El-Bassossy, Numan Salah, Magda Hagras. Ajwa Nano-Preparation prevents Doxorubicin associated cardiac dysfunction: Effect on cardiac ischemia and antioxidant capacity. Integrative Cancer Therapies Volume 18: 1– 9 2019 DOI: 10.1177/1534735419862351

 

160. Vincenzo; Soliman, Nada; Sobti, Praveen; Al Jaouni, Soad; El Kholy, Mohamed;et al. beta-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint De Sanctis, Mediterranean Journal of Hematology and Infectious Diseases, Volume: 9 Accession number: WOS:000397708300001 2019, Impact Factor 2018. 1.586

 

161. Abdel-wahab A. Alsenosy, Ali H. El-Far, Kadry M. Sadek, Safinaz A. Ibrahim, Mustafa S. Atta, Ahmed Sayed-Ahmed, Soad K. Al Jaouni, Shaker A. Mousa, Graviola(Annona muricata)attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabeticrats, PLOS ONE Impact factor:2.776 , 2019

 

162. Highlights of Past EHA (HOPE) Middle East & North Africa (MENA) September 12-14, 2019, Cairo, Egypt, participating as chairperson and one research in SCD challenge in Transfusion with multiple antibodies .

 

163. Vincenzo De Sanctis, Ashraf T. Soliman, Shahina Daar, Heba Elsedty, Salvatore Di Maio, Mohamed Yassin, lhab El-Hakim, Antonis lGttamis,Vassilis Ladis, Duran Canatan s, Joan-Lluis Vives Corrons e, Demetris Mariannis, Soteroula Christou, Mehran Karimi, Nada Soliman, Soad Al Jaouni, Dulani Kottahachchi, Shruti lGkkar, Maria Concetta Galati, Giuseppe Raiola, Saveria Campisi ls, Christos Kattamis, Detecting Glucose Related Disturbances in Patients with Transfusion Dependent Thalassemia (TDT): From old to new concepts, Bivisk ltaliana di Medicina dell'Adolescenza - Volume 17, n.2, 2019

 

164. Vincenzo De Sanctis, Ashraf T. Soliman, Shahina Daar, Niveen Alansary Maria Concetta Galati, Soteroula Christou, Saveria Campisi, Giuseppe Messina, Mohamed Yassin, Duran Canatan Salvatore Di Maio Soad Al Jaouni, Giuseppe Raiola, Mehran Karimi, Valeria Kaleva, Shruti Kakkar, Demetris Mariannis, Christos Kattamis, Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives, In Press

165. Steve Harakeh, Wafaa S. Ramadan, Mohammed S. Al Muhayawi, Soad Al Jaouni, Shaker Mousa, Khalid Rehman Hakeem, Effects of pomegranate and ellagic acid on the histopathological hallmarks of Alzheimer’s disease in the hippocampus of aluminumchloride induced rat model, Journal of Tropical Medicine 2019

 

166. Ali H. El-Far, Babatunji E. Oyinloye , Masood Sepehrimanesh , Mahmoud A. Gab Allah , Ibrahim Abu-Reidah , Hazem M. Shaheen , Iman Razeghian-Jahromi , Abd el- wahab A. Alsenosy , Ahmed E. Noreldin , Soad K. Al Jaouni and Shaker A. Mousa, Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery, Current Drug Discovery Technologies, 2019, 16, 2-10

 

167. Mohammed S. Almuhayawi,Wafaa S. Ramadan, Steve Harakeh^, , Soad K. Al Jaouni^, Dhruba J Bharali^, ,Shaker A Mousa and Saad M Al Muhayawi Neuro Protective and Therapeutic Effect of Pomegranate Extract and its Nanoparticles in AlCl3 Induced Alzheimer Rat Model, in press.

168. Soad K. Al Jaouni ,30^th Annual Scientific Meeting in Internal Medicine on Hematology, November 26^th- 28^th , 2019, Deparmtent of Internal Medicine King Fahad Hospital of the University Imam Abdulrahamna bin Faisal University, Participate 2 oral presentation ( SCD & transfusion ).

169. Soad K. Al Jaouni ,The first forum Ajwa Al Madina Al Munawara 1-4 December,2019, Effects of Phoenix dactylifera Ajwa in Evidence-Based Medicine to Improve the Quality of life

 

170. Vincenzo De Sanctis, Ashraf T. Soliman , Shahina Daar , Niveen Alansary, Antonis Kattamis, Myrto Skafida, Maria Concetta Galati, Soteroula Christou, Saveria Campisi, Giuseppe Messina, Mohamed Yassin, Duran Canatan, Salvatore Di Maio, Soad Al Jaouni, Giuseppe Raiola, Mehran Karimi, Valeria Kaleva, Shruti Kakkar, Demetris Mariannis and Christos Kattamis, A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience, Mediterranean Journal of Hematology and Infectious Diseases.2020 In Press .

 

171. The 4^th International Conference on Quality and Evidence based in Prophetic Medicine23^rd & 24^th February 2020 (with 2 talks) Awad of the First Sheikh Zayed International for Complementary Medicine 25^th February 2020 at Abu Dhabi , UAE, participating in organization, Head of Scientific committee, Prazetend

 

172. The 18^th Saudi Society of Hematology Congress and the 8^th Pan Arab Hematology Association Congress in Muscat, Oman February 27-29, 2020. Organizer, Scientific committee and Speaker.

 

173. Healthcare and Pediatric Nutrition Conference, March 30-31, 2020, Dubai
     United Arab Emirates, Speaker

Booklets in Arabic

• Al Jaouni SK, Smith G. Guide to Transfusion Medicine. 1997. (In Arabic and English).
• Soad Al Jaouni & Dr. Nadia Gannem,
  Blood Diseases & Osteoporosis(Arabic)
• Soad Al Jaouni, Role of Prevention of Hereditary Blood Disease. (Arabic)
• Soad Al Jaouni, Anemia & Malnutrition. (Arabic)
• Soad Al Jaouni, Premarital Screening
• Dr. Soad Al Jaouni, Information About Inherited Blood Diseases
• Dr. Soad Al Jaouni, Inherited Blood Diseases (Arabic)
• Dr. Soad Al Jaouni Prevention of Thalassemia Major and Sickle Cell Anemia (Arabic)
• Prof. Soad Al Jaouni, Prevention of Cancer (Arabic)

Pamphlets (Arabic) written by Dr. AlJaouni

• Hereditary Blood Diseases
• Prevention from Cancer
• Prevention from Thalassemia Major and Sickle Cell Anemia
• Cancer and your environment and how to prevent.

 

 

 

1. The 4rd International Conference On Quality And Evidence Based In Prophetic Medicine 23-25 February 2020,Abu Dhabi Rotana Beach Hotel, United Arab Emirates

 

2. First Sheikh Zayed International Award for Complementary Medicine and Congress from 25 February 2020Abu Dhabi UAE.

 

3. 18th Annual Meeting of Saudi Society of Hematology/9th Pan Arab Hematology Association Congress from February 27.29, 2020 at Muscat , Oman.

 

4. Healthcare and Pediatric Nutrition Conference March 30-31, 2020, Dubai United Arab Emirates

 

5. 29th Regional Congress of the ISBT 2019, in conjunction with Swiss Transfusion SRC and the Swiss Association for Transfusion Medicine, Basel, Switzerland  June 22 - 26,  2019.        Participated with Oral presentation.

 

6. . 24th Annual Meeting of EHA Congress June 13-16, 2019, Amsterdam, Netherlands participating with 4 oral participation.

 

7. Middle East Diabetes & Obesity Congress 2019 March 08-11, 2019 Park Hyyat Hotel, Jeddah,Saudi Arabia, CME 36 hrs. Participated as Chairperson.

 

8. 18th Annual Laboratory Management and Medicine Congress (MEDLAB Congress 2019) at Dubai International Convention and Exhibition Centre, Dubai, UAE, February 04-07, 2019. The Cleveland Clinic Foundation Center for Continuing Education. CME 33 hrs. Participated as Oral presentation (Disease control of thalassemia improved the survival and quality of life 28 years experience).

 

9. Holistic Approach to Improve Healthcare In Collaboration with Family Medicine Residency Program, February 06, 2019 at Abu Dhabi UAE. Participated with 2 oral presentations.

 

10. 17th Annual Meeting of Saudi Society of Hematology/8th Pan Arab Hematology Association Congress from February 01-04, 2019 at Madinah Al Munawarah, KSA. CME 31 hrs. Participated with Oral presentation.

 

11. First International Conference on Nanotechnology Theory and Applications, December 2018, Cairo, Egypt. Participated with 2 oral presentations.

 

12. Highlights of Past EHA HOPE Cairo 2018. September 27-29, 2018, Cairo, Egypt. Participated as Chairperson. CME 9 hrs.

 

13. International Colloquium on Oncology & Cancer Research, September 19-20, 2018 at Millennium Airport Hotel, Dubai, UAE. Participated with Oral presentation.

 

14. Global Health Exhibition Medical Laboratory Medical Laboratory Management Conference. September 10-12, 2018.  Riyadh, Saudi Arabia. Participated in the  Exhibition.

 

15. The International Conference on Alternative and Traditional Medicine, July 23-25, 2018, Rome, Italy. Participated with 1 oral presentation.

 

16. 19th International Thalassemia Day Conference, May 9-10, 2018, Intercontinental Semiramis Hotel, Cairo, Egypt.

 

17. The 3rd International Conference on Quality and Evidence Based in Prophetic Medicine, Rotana Beach Hotel-AlThuraya Hall-Abu Dhabi, April 21-22, 2018. Organizer & Speaker. CME 16  hrs.

 

18. The 4th International Conference of the Saudi Society of Transfusion Medicine, SCITECH, Alkhobar, KSA, March 31, 2018 -April 02, 2018 as a Chairperson. CME 24 hrs.

 

19. The 12th World Hematologist Congress, March 15-16, 2018, London UK. Participated as a Speaker and Oncology Modulator.

 

20. The 16th Annual Meeting of Saudi Society of Hematology, VII Pan Arab hematology Association Congress (Advances and Challenges in Hematology), February 24-25, 2018 at Intercontinental Hotel, Jeddah, KSA as a  Speaker and Organizer. CME 24 hrs.

 

21. Bridging Gaps in Oncology BGO 17 Congress, in Intercontinental City Stars, Cairo Egypt in November 8-10, 2017. Participated as Honorable Speaker.(Natural products can improve the quality of life in Pediatric Cancer patients: Evidence-Based at University Hospital Single Institute at Kingdom of Saudi Arabia).

 

23. Soad Al Jaouni and Samy Selim (2017). Antipseudomonal and Antibiofilm Activity of Quercetin extracted from Ajwah date palm (Phoenix dactylifera). 3^rd International Conference on Natural Products Utilization: from Plants to Pharmacy Shelf (ICNPU 2017), which will take place on 18-21 October 2017, Bansko- Bulgaria.http://www.icnpu.com/2017/

 

24. 14th International Conference on Malignant Lymphoma, September 29-30, 2017, Jeddah InterContinental Hotel.

 

25. Highlights of Past EHA (HOPE Cairo 2017) September 14-15, 2017 in Cairo, Egypt. CME 9 hrs.

 

26. Soad Al Jaouni , Natural Products Can Improve The Quality Of Life In Pediatric Hematology/Oncology Patients: Inspired By Prophetic Medicine , 10th Paediatric Haematology/Oncology Symposium and TCD Workshop Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia Sun-Wed 19-22 March, 2017

 

27. The CHSS Conference Medical Herbs in the Arab Gulf: Mapping an Interdisciplinary Approach, in Doha Qatar in October 18-19, 2017. Participated as Honorable Speaker. (Phoenix dactylifera fruit minimizes infection, hospitalization and mortality among Pediatric Cancer patients, single center experience).

 

28. Steve Harakeh, Josiane Semaan, Marwan El-Sabban, Soad K. Al Jaouni, Rania Azar, Mona Diab-Assaf Thymoquinone Inhibits Proliferation and induces apoptosis in leukemic

     

      cells. American Association for Cancer Research (AACR)Washington D.C. 1-5 April, 2017 Annual Meeting 110

 

29. The 7th World Hematologists Congress, Barcelona, Spain, May 08-09, 2017.Participated as Honorable Speaker. (Hydroxyurea an effective therapy to avoid splenectomy  in Sickle cell disease and Thalassemia: Single Institute experience in Saudi Arabia, Nigella Sativa and honey improves quality of life in Kostmann syndrome: Case Report,The Saudi experience on the effects of endocrine complications and its morbidity in thalassemia.

 

30. Survival of Hematology/Oncology Facts: Evidence-Based  28 Feb.2017.CME 8 hrs.

 

31. Mona Diab-Assaf, Josiane Semaan, Marwan El-Sabban, Soad K. Al Jaouni, Rania Azar, Steve Harakeh . Thymoquinone Results in the modulation of TGF family, p53, p21 and Bcl-2α in leukemic cells. 23th LAAS International. Lebanon 6-7 April, 

 

32. The 6th Pan Arab Hematology Conference, February 11-13, 2017, Regency Hotel, Kuwait.

 

33. Selim, S. Al Jaouni (2016).Vitamin E (α-tocopherol) Contents and Antimutagenicityx potentials Talbina (Hordeum vulgare L.) P-MIS-098 S. Volume 283, Issue Supplement S1, Special Issue: 41^st FEBS Congress, Molecular and Systems Biology for a Better Life, Ephesus/Kuşadasi, Turkey, September 3/8, 2016. Page 192 http://onlinelibrary.wiley.com/doi/10.1111/febs.13808/epdflx

 

34. The 2nd MEGA Conference on Thalassaemia &other Haemoglobinopathies, Amman, Jordan, November 11-12,  2016. Participated with two abstracts.

 

35. The 41st FEBS Congress Molecular and Systems Biology for a better life, Ephesus/Kusadasi, Turkey, September 03-08, 2016.Vitamin E (α-tocopherol) contents and antimutagenicity potentials Talbina (Hordeum vulgare L.)

 

36. The International Conference of Pediatric Oncology, Toronto Canada, August 11-13, 2016. Participated as Honorable Speaker with 3 researches. (Effect of Phoenix dactylifera palm date (Ajwa) on infection, hospitalization and mortality among Pediatric Cancer patients atsingle Medical Institute in Saudi Arabia. A pilot trial of Saudi honey on oral mucositis among pediatric cancer patients. Novel Methodology ofDetecting Minimal Residual Disease in Acute Leukemia byUsing FTIR (Spectroscopy).

 

37. The 2nd International Conference on  Prophetic Pharmaceutical Quality Medication Conference, King Faisal Auditorium at King Abdul Aziz University, Jeddah Kingdom of Saudi Arabia on April  05-07, 2016.CME 30 hrs. Participated with 4 research. (Novel product can improved quality of life and survival in Kostman's syndrome, Cupping can treat severe bone pain in thalassemia, Antimicrobial effect of dates in Pediatric Hematology/Oncology, Pasteurized camel milk in control study in PediatricHematology/Oncology patient).

 

38. V Pan Arab Hematology Congress and XIV Saudi Society of Hematology Congress IV Joint Meeting with European Hematology Association on February 11-13, 2016, Cairo Egypt. (Splenectomy can be avoided  in Sickle cell disease and Thalassemia: Single   Institute experience).

 

39. Pan Arab of Thalassemia and hemoglobinopathies in Emirates, Abu Dhabi, November 19 -21, 2015. Participate with 2 abstract (Honey improves the quality of life outcomes and decreased the painful crisis in sickle cell disease) (Hydroxyurea Therapy in Sickle cell disease and Thalassemia can eliminate Splenectomy Effectiveness of regular oral intake of  Phoenix dactyliferous palm dates in reducing morbidities and mortality among pediatric hematology/oncology patient single institute experience in Saudi Arabia.  Novel therapy for bone pain in sickle cell disease and (thalassemia).

 

40. 20th European Hematology Society Congress June 11-14, 2015, Vienna, Austria. Participated with 3 abstract.CME 19 hrs.

 

41. Second Annual Expert Annals Assembly for Saudi Clinical Practice. Guidelines ; Development 2015 with Mac Maxter University in Canada. March 15-18, 2015.

 

42. Highlights of the 19th Congress of EHA at the IV Pan Arab Hematology Congress, XIII Saudi Society of Hematology Congress on February 5-7, 2015, Abu Dhabi, U.A.E. Speaker and Organizer of the IX International Network of Endorine complication in Thalassemia (Saudi experience in the Endocrine complications for thalassemia major patients). Poster (The role of nutrition in SCD). One presentation as a Speaker " The Saudi experience on the effects of endocrine  complications and its morbidity in thalassemia" and (2 posters) Role of Nutrition in Sickle Cell disease and quality of life outcomes, Malnutrition increased morbidity and  mortality among  pediatric hematology/oncology patients, a single institute experience in Saudi Arabia.

 

43. 40th Annual Conference of Indian Society of Human Genetics. International Symposium on Genomics in Health and Disease on January 28-30, 2015, India. Participated with (1 poster)Glucose-6-Phosphate Dehydrogenase Deficiency- Who, When, Why And How.

 

44. 11th International Conference of the Egyptian Society of ESHR update in Hematologyx on October 22-24, 2014, Grand Nile Tower, Hotel Cairo, Egypt. Participated as a Chairperson.

 

45. 19th Congress of EHA participated with 3 researches on June 12-15, 2014, Milan, Italyx 23 EHA-CME.

 

46. 4th Emirates Hematology Congress on March 20-22, 2014, Abu Dhabi.CME 17 hrs.

 

47. 2nd International Conference of Saudi Society of Transfusion Medicine, Hyatt Parkx Jeddah, on April 12-14, 2014. CME 30 hrs.

 

48. 12th Annual Hematology Congress, 3rd Pan Arab Hematology Congress on February 11- 13, 2014, Jeddah, KSA. Participated with 3 research. CME25 hrs., EHA CME 10

 

49. Prophetic Pharmaceutical Quality Medication, December 10-12, 2013 in Madinah Munawarah, KSA. CME 30 hrs.

 

50. 13th International Conference on Thalassemia & Hemoglobinopathies in Abu Dhabi National Exhibition Centre on October 20-23, 2013. Participated with 2 research papers 1 oral and 1 poster. (A comprehensive care in SCD can improve the quality of life outcomes) (The urgent need of primary prevention of stroke in children with sickle cell disease in Saudi Arabia using transcranial doppler). CME24 hrs.

 

51. 18^th Congress of EHA in Stockholmsmassan (Stockholm International Fairs) in Stockholm, Sweden, on June 13-16, 2013. Participated with 2 researches.CME 23 hrs.3^rd Emirates Haematology Conference in Dubai, United Arab Emirates on March 7-9, 2013. Participated with 2 papers (1 Oral & 1 Poster).

 

52. 3^rd Pan European Conference 2012 in Limassol, Cyprus on October 24-26, 2012. (Poster).

 

53. Saudi Arabia Pediatric Hematology/Oncology Society Symposium 2012 in Riyadh Saudi Arabia, on September 19-20, 2012.(2 Abstract).

 

54. MedicReS World Congress 2012 in Vienna, Austria on June 2012, in collaboration with Harvard Medical School. A research work had been accepted as a Poster to be presented in this Congress. (Using a new integrative approach with refractory cases in pediatrics hematology/oncology: Clinical trial I/II at King Abdulaziz University Hospital in Saudia) and (New integrative approach with standard care of chemoradiotherapy-induced oral mucositis in pediatric cancer patient).

 

55. International Conference Allogeneic Cellular Gene Therapy in Hemoglobinopathies University of Rome, Italy on  May 2012 invited as Speaker.(Sickle cell in Saudi Arabia). CME 5 hrs.

 

56. International Conference of Thalassemia May 09-10, 2012, Cairo, Egypt. Participated with a research work (Outcome of Sickle Cell disease complications and quality of life).

 

57. The 10^th International Congress of ESPHO Blood and Bone Marrow Disorders in Children Adolescents: Genetics and Beyond in Alexandra, Egypt on March 29-30,Participated with 2 posters.

 

58. European School of Oncology-Educational Cancer Convention Lugano, What’s New in Haemato-Oncology? April 21-22, 2012, Lugano, Switzerland. Participated with three research work (3 posters) (Health and quality of life outcomes in patient with sickle cells disease).Published in Oncology Hematology Vol. 82, Suppl. 1 April 2012; pp: S17-S18. CME 10 hrs.

 

59. 1^st International Conference for Saudi Society of Transfusion Medicine. March 5-8, 2012, KSA. CME 25 hrs.

 

60. 1^stCEOR’s International Symposium on Osteoporosis and Bone Health as part of the

    launching of the Prince Sultan Bin Abdulaziz National Campaign for the Prevention of Osteoporosis. February 8-9, 2012, Laylatee Gala Hall, Jeddah, KSA. CME 20 hrs.

 

61. X International Congress of the Saudi Society of Hematology and First Pan Arab Hematology Congress, Al Madinah Al Munawarah, on December 21-22, 2011 invited as a Speaker.  Member of Scientific Committee and present three papers one oral and two posters. (Neonatal screening for hemoglobin disorders and g6pd deficiency: national strategy toward a uniform screening panel  and system).CME 30 hrs.

 

62. Montreal International Translational Medicine Conference in Montreal, Quebec, Canada on November 3-4, 2011 invited as a Speaker. (Primary Thrombophilia in Saudi Arabia).

 

63. XIII Plasma Quality Program Modern Management of Haemophilia and von Willebrand

    Disease, Dubai, United Arab Emirates on October 20, 2011 present as a Speaker case report.(A case report of Von Willebrand disease).

 

64. 16^th Congress of European Hematology Association EHA. Abstract accepted June 2011. (A successful approach using a new integrative approach with refractory sixteen  cases in pediatrics hematology/oncology: Clinical trial I/II  at King Abdulaziz University  Hospital in Saudia).

 

65. 12^th International Conference on Thalassemia and other Haemoglobinopathies 14^th TIF International Conference for Patients and Parents May 11-15, 2011, Antalya, Turkey.Participation with abstract. (Prevalence of bone disease and quality of life among sickle cell anemia: Single institute experience: Jeddah, Kingdom of Saudi Arabia).

 

66. International Conference European School of Hematology (ESH) on Update on the Management of Haematological Malignancies March 25-27, 2011, Cairo Egypt. Participation with abstract. (Honey reduces chemo-radiotherapy induced mucositis among Pediatric Cancer patients at King Abdul Aziz University Hospital in Jeddah, Kingdom of Saudi Arabia).

 

67. National Genomic Day and International Genomic Conference CEGMR marking the Second Annual National Genomic Day February 15-16, 2011, King Fahad Medical Research Center, Jeddah, KSA. Participation with abstract.(Molecular characterization of G6PD deficiency in Jeddah, Saudi Arabia).

 

68. 21^st International Thrombosis Congress. July 6-9, 2010, Milan, Italy. Participated with poster. (The prevalence of Factor V Leiden among the Saudi population attending  the anticoagulant clinic: 10 years  experience at King Abdulaziz University Hospital Jeddah,  KSA).

 

69. 15^th Congress of European hematology Association. June 10-13, 2010, Barcelona, Spain. Participated with abstract. (Quality of life among SCD and bone complications).1^1th International Thalassemia Conference. May 8-9, 2010, Cairo, Egypt. Participated with oral presentation.(Causes of death among thalassemia major 14 years experience).

 

70. The 8^thInternational Congress Egyptian Society of Pediatrics Hematology Oncology(ESPHO). Cairo, Egypt March 25-26, 2010, Alexandria, Egypt. Participated 3 papers. (The prevalence of osteopoieresis among pediatric oncology patients, at King Abdulaziz University Hospital, Jeddah, KSA), (Medical student awareness of hemoglobin disorders and G6PD deficiency).

 

71. 3^rd Pan Arab Human Genetics Conference, March 13-14, 2010, Dubai, United Arab Emirates. Participated 4 posters.CME 7 hrs. (Frequency of thalassemia disorders andhemoglobinopathies in Jeddah, Western Saudi Arabia), ( Molecular characterization of alpha-thalassemia among Saudi population in jeddah, KSA), ( Molecular characterization of G6PD deficiency in Jeddah, Western, Saudi Arabia) and (Medical student awareness of hemoglobin disorders and G6PD deficiency in Jeddah, Western Saudi Arabia).

 

72. 7^th Scientific Conference for Medical Students in the GCC Countries, February 13-16, Participated with poster.CME 10 hrs.The International Conference of the VIII Saudi Hematology Society, Jeddah 16-17 Dec. 2009. Participating as a Speaker also a member of Scientific Committee. CME 15 hrs.and Accredited by the American Medical Continuous Education. CME 16 hrs.

 

73. International Congress Qatar Medical Exhibition and Congress 2009 (Q-MEDEC2009) Participating the Workshop, as a Speaker Qatar 12-15 Dec. 2009.CME 4 hrs.

 

74. XXth Congress of International Society of Haematology-European and African Division (ISH-EAD) Cairo Egypt, 10-13 October 2009 Participated with 3 abstract. One oral presentation( Prevalence of thalassemia disorders and hemoglobinopathies in Jeddah, Western Saudi Arabia) and two poster presentation.(Neonatal screening of G6PD deficiency: Diagnostic challenge and clinical correlation)CME 20 hrs.

 

75. 14^th Congress of EHA, June 4-7, 2009, Berlin Germany *Participating. (2 abstracts). International Symposium in Women Ageing Participating with the Poster. CME 15 hrs.Inherited Hemolytic Anemia Update Conference and Workshop in Collaboration with French group. *Organizer and participation by Lectures. May 4^th 2009 KAUH, Jeddah.CME 8 hours accredited by American Academy of CME 7 hrs.

 

76. Mini AABB Transfusion Medicine KAUH, Jeddah April 13-15, 2009 *Chairperson. CME 15 hrs.

 

77. 16^th Egyptian Society of Pediatrics Hematology Oncology. Cairo, Egypt March 26-28, 2009 * Participating 2 papers.

 

78. 4^th Oncology 2008, 4^th Oncology Update Symposium February 23-25, 2009 KFSH & RC, Jeddah. Accredited by American Academy. CME 12 hrs.

 

79. 4^th International Neonatal Conference 2009, February 16-18, 2009 * Participated Lecture.KFA Hospital Jeddah, CME 29 hrs.

 

80. Pan-Arab Blood Transfusion Conference 7^th Arabian and 4^th GCC February 15-29^th, 2009 Doha, Qatar *Participated by Poster.

 

81. Meta Analysis Symposium and Workshop KFSH & RC, Jeddah February 17-18, 2009. CME8 hrs.

 

82. 50th American Society of Hematology (ASH) Congress 2008 USA participated with *2papers accepted will be published in Abstract Blood November, 2008. #4570,#4677International Conference on Nanotechnology: Opportunities and Challenges (ICON 008). King Abdulaziz University. Center of Nanotechnology. June 17-19, 2008. Poster Presentation. CME Accredited

 

83. 13^th Congress of European Hematology Association EHA. June 19-22, 2008, Copenhagen. Will participate with two abstract accepted. #1355 & #1068.

 

84. 9^th International Thalassemia Conference Cairo University, Egypt from May 7^_9, 2008.(Poster Presentation& Oral Presentation).

 

85. 7^th Saudi Hematology Society Congress, in King Fahad Medical City in the cooperation of American Association for Blood Bank (AABB) participated with paper and poster presentation.CME:22+5May 19-22, 2008

 

86. 6^th ESPHO, Egyptian Society of Pediatric Hematology Oncology, March 27-28, 2008, Cairo Egypt, participate with 2 papers accepted 1 oral and 1 Poster Presentation. April 2008.

 

87. Beating Blood Clots in Bahrain, Leo Pharma mini-symposium, January 25, 2008. International Saudi Conference of Advanced Laboratory Medicine. October 30-31, 2007. Organizer of the Hematology Session and Coordinator of Diagnostic Workshop. CME: 30 hrs.

 

88. 12^th Conference of European Hematology Association (EHA). Vienna, Austria.  June 7-10, 2007.* 2 paper accepted. 1. Pattern of Bone Disease Among Thalassemia Patient. Haematologica. The Hematology Journal vol. 92(S1) pp 428-429 June 2007. 2. Growth Factor (GCF) Can Cause Cataract. Hematologica. The Hematology Journal vol. 92(S1) pp 542 June 2007.2 abstract accepted.

 

89. 8^th International Thalassemia Conference. Cairo University, Egypt. May 8-10, 2007.
Participating withoral presentations.

 

90. 5^th International Congress of Egyptian Society of Pediatric hematology/Oncology (ESPHO) March 2007, Cairo. *Pediatric Thrombophilia. (Poster Presentation).Genetic Conference.  European Hospital.  Paris, France.  Jan. 2007. (Novel Gene Mutations of G6PD Among Saudi Patients).

 

91. International Symposium Oncology Update – 2007. 27-28 February 2007. King Faisal Specialist Hospital & Research Centre, Jeddah, KSA. CME:12

 

92. International Conference of Venous Thromboembolism, Current Trends & Future Directions. 4-5 February 2007 in King Faisal Specialist Hospital and Research Centre, Jeddah, KSA. CME: 8. Accredited by CME: 5 by McMaster University, Canada

 

93. 47^th ASH Annual Meeting participated with an article #111. (Tinzaparin in the Management of Painful Vaso-Occlusive Crisis of Sickle Cell Anaemia). USA

 

94. International Saudi Symposium on Hemostasis and Thrombosis (INSSH), Jeddah, Saudi Arabia, November 25-27, 2006. Speaker, Workshop Organizing / Member of Scientific and Organizing Committee. CME: 17

 

95. 11^th Conference of European Hematology Association (EHA).   June 15, 2006.* 2 accepted presentations – (1) Molecular Clinical Characterizations in G6PD in Western Saudi Arabia Abstract #0061 (2) Survival and Disease Complications of TM – 14 Years Experience Abstract #0378(3) The Safety of avoiding pre-operative transfusion in patients with sickle cell anemia Abstract #1136. HAEMATOLOGICA 2006;91(supplement 1)   CME: 15.75. Participated with 2 posters.

 

96. Advanced Presentation Skills Workshop. King Abdulaziz University Hospital.  May 14, 2006.  CME accredited.

 

97. 7^th International Thalassemia Conference. Cairo University, Egypt.  May 7-10, 2006.* (Presentation – 15 Years Experience of King Abdulaziz University Hospital in Disease Complication and Control of TM).

 

98. Conference of Abdulaziz University Hospital to Build up Better Family. April 2-4, 2006.  Participated in preparing a course for pre-marital medical awareness.*

 

99. 4^th International Congress of Egyptian Society of Pediatric Hematology-Oncology (ESPHO). Cairo, Egypt.  March 30-31, 2006.* (3 papers accepted and presented). (1) Neonatal Screening of G6PD (2) Systemic Mastocytosis and Hematological Review (3) Thalassemia Update. (Poster Presentation).

 

100. 10^th International Conference of Thalassaemia and Hemoglobinopathies (TIF). January 7-10, 2006.* (3 papers accepted).  (1) Safety of Avoiding Transfusion in Pre-operative Preparations in SCA (2) Disease Complications of TM (3) Serum Ferritin is a Poor Indicator for Early Myocardial Iron Overload. Dubai, UAE. Abstract # A241, A165.

 

101. 47^th ASH Annual Meeting, USA. December 2005.  Abstract # 554495 (Tinzaparin in the Management of Painful Vaso-Occlusive Crisis of SCA). Blood Journal of the American Society of Hematology vol. 106 #11 November 2005.

 

102. 3^rd International Conference on Advanced Medicine. November 2005. CME: 18 hrs.

 

103. President of ISSPHO & Speaker. International Saudi Symposium of Pediatric Hematology/Oncology (ISSPHO). November 21-23, 2005. [CME: Whole symposium = 17 hrs; Nursing satellite = 5 hrs; Hemophilia satellite = 6 hrs; and Alternative medicine = 5 hrs.]. Total CME: 33.

 

104. XXX^th World Congress of International Society of Hematology (ISH) Istanbul Meeting, September 28 to October 02, 2005. EHA CME: 60.

 

105. The Fourth Middle East Thalassemia Investigators And Thought Leaders MeetingExjade ESCALATOR Study Investigator Meeting IV, September 01-03, 2005, Amsterdam, Holland.

 

106. Annual Conference of Royal College of Physicians & Surgeons of Canada, Vancouver, September 22-24, 2005. *2 papers submitted.

 

107. Exjade Escalator Study Investigator Meeting IV, Amsterdam, Netherlands, September 01-03, 2005.

 

108. Ambulatory Pediatrics, KAUH speaker. May 11, 2005 (3^rd Rabi Thani 1426). CME accredited.

 

109. Oncology Update 2005. [CME 15 hrs]. KFSH&RC Jeddah.

 

110. The Second International Congress of Egyptian Society of Pediatric Hematology/Oncology (ESPHO) Speaker. 31^st March – 1^st April 2005, Cairo, Egypt.

 

111. Workshop about High Educational Opinion of Prince Abdullah Bin Abdulaziz Al Saud. January 30 – February 1, 2005, KAUH.

 

112. Medical Statistics and Research, 14-15 January 2004 (22-23/11/1424), Medical Education Unit, KAU.

 

113. The 5^th International Symposium on Hematology and Transfusion Medicine, March 14-17, 2004/Muharram 23-26, 1425H, King Fahd Cultural Center, Riyadh, S. A.*

 

114. The Role of Comb Test in the Assessment of DNA Damage During Therapy of Leukemia and Lymphoma.

 

115. Workshop on Donor Recruitment, KAAUH, KAU, 22 March 2004.* Chairperson

 

116. First Saudi International Transfusion Medicine Symposium (SITMS), 22-25 March 2004, KAU. [CME 20]* Member of the Scientific Committee*Chairperson & Attended.

 

117. The First International Congress of ESPHO, The Egyptian Society of Pediatric Hematology/Oncology; Cairo, Egypt, 8-9 April 2004. *Participant, Attendee and Speaker.

 

118. Saudi – BMT 2004 International Conference in collaboration with Princess Margaret Hospital, Toronto, Canada; 12-14 April 2004, King Faisal Specialist Hospital & Research Center, Jeddah. #305/3/2004. Dated: 22/1/1425. [CME 15]Participant & Attendee.

 

119. Thalassemia Day, King Fahd Medical Research Center, KAU; May 8, 2004.National Meeting and Patient Education.

 

120. Diagnostic Workshop for Hemoglobinopathies (Council of Health Specialties), King Fahd Medical Research Center, Hematology Research Lab, KAU, 9^th of May 2004#3/1363. Dated: 15/3/1425. [CME 6] *Organizer of the Workshop & Lecturer.

 

121. General Principles of Assessment in Health Sciences Program Workshop, Wednesday,28 April 2004 (9 Rabi’ I 1425H), Medical Education Unit, KAU. #2/918/3/2004.Dated: 24/2/1425. [CME 2.5]

 

122. The First International Congress of (ESPHO) Egyptian Society of Pediatrics Hematology Oncology, April 8-9, 2004, Cairo, Egypt (paper presentation: Adeno-tonsillectomy without Blood Transfusion in Sickle Hemoglobinophaties).

 

123. Designing & Executing an Objective Structured Clinical Exam (OSCE) Workshop, Sunday, 2nd May 2004/13 Rabi’ I 1425, Medical Education Unit, KAU. #2/918/3/2004. Dated: 24/2/1425H. [CME 2.5].

 

124. Annual Conference of the Royal College of Physician and Surgeon, Canada, 75^thAnniversary, Ottawa, September 30 to October 2, 2004. Accepted 2 Abstracts.

 

125. Supportive care in Oncology International symposium. 24-26/March/2003, KFSH &Research Center – Jeddah [CME12].

 

126. Continuous Medical Educational at King Abdulaziz University Hospital Educational for Public & Patient Lecture (Inherited Blood Diseases] 11 March 2003.

 

127. The second Annual Meeting for scientific Research 30-31/March/2003.

 

128. Summer Educational Factional for better life. 1/7/2003, Al-Andalus School [Pre-marital screening]. Attendance.

 

129. Venous thrombosis & clinical practice. 22-23/April/2003 [CME 8]. King Abdulaziz University, Jeddah. Scientific Committee and Chairperson.

 

130. 2^nd annual hematology Symposium. 24/Sept/2003, King Faisal Specialist & Research –Jeddah, Saudi Arabia [CME 7].

 

131. The second Middle East Thalassemia investigators & through leaders meetings. 3-6/Oct/2003, Luxar, Aswan - Egypt [CME 5]. Attendance.

 

132. The 9^th International Conference on Thalassemia and Hemoglobinopathies *(Poster 107),October 15-19, 2003 Parlermo, Italy.

 

133. Program for workshop on “Developing Strategic Action Plans for Improving Teaching& Learning Environments of Faculty of Medicine (1424-1430 H) 15-16 December2003, CME 10. Participating.

 

134. A Course to Provide an Introduction to Statistical Thinking and Statistical Methods for Researchers, King Fahd Medical Research Center, Jeddah, Saudi Arabia 20 December2003, for four weeks.

 

135. What cardiologist expect from laboratory? 14/1/2002, Bagedo & Dr. Erfan Hospital[CME 2]. Registration slip # 2437.

 

136. Continuing educational activity in Transfusion medicine. 20/1/2002, Ministry of Health (MOH), King Fahd General Hospital.

 

137. Dar Al Hekma Collage. 10/3/2002 (Educational Week). [Is Hereditary Blood Disorders Common for Saudi Arabia].

 

138. Jeddah Haematology Club, “Unwinding and Beyond: A Tale of Helicase Homologue”, Tuesday, 19^th of March 2002.

 

139. Ideal utilization of lab investigation. 17/April/2002, Medina Munuwar, MOH [CME 5].

140. E-learning& e-health care Workshop. 10-11/Safar/1423 – 23-24/April/2002 [CME 6].

 

141. College of Science, Research Day. 28/April/2002, KAAU.

 

142. Medical Curriculum Development. 6-8/May/2002 [CME 6].

 

143. Recent Advances in Laboratory Medicine. 5-6/Oct/ 2002, Dr. Erfan Hospital in collaboration with Royal College of Pathologist. UK. [CME 10] & participate as Chairperson.

 

144. Educational Program in Blood Donation. 19-23/Oct/2002, KAAU.

 

145. Clinical Exams, King Abdulaziz University & KFSH. 28-30/Oct/2002.

 

146. 1^st Oncology course for nurses. 21-25/Dec/2002, King Abdulaziz Hospital [CME  26].

147. International Thalassemia Workshop in collaboration with TIF. 28/Oct/2002, King Abdulaziz University (KAUH). Present a lecture [Current Policies & Clinical Care of Thalassemia].

 

148. Assisting Application of Knowledge with Written Test & Objective Structure Clinical Exam Workshop (OSCE), 28-30 October 2002. CME 14 hours at King Abdulaziz   Medical Center.

 

149. 44^th Annual Meeting. American Association of hematology (ASH).  Philadelphia, USA. Blood Volume 10 (11) Abstract # 3923 – 2535, 6-10/Dec/2002. (1) Abstract # 3535 - The     

      

     Safety of Avoiding Transfusion Preoperatively in Patients with Sickle Cell   Hemoglobinopathies (2) Abstract # 3923 - Primary Thrombophilic States in Saudi Arabia, a Different Pattern.

 

150. Sejeny, SA, Quaife, R., Damanhouri, G., Hassounah, F., AlJaouni, S., Omer, A.Frequency and spectrum of b-Thalassaemia mutations in the Western Region of Saudi Arabia. Presented at the International Thalassaemia Conference "Malta" 4-9 April 1997.

 

151. American Association of Blood Bank Orlando, Florida USA.

 

152. 1995 Annual Meeting – Royal College of Physicians & Surgeons of Canada.

 

153. September 13-17, 1995 Montreal, Canada (Immunoglobulin level as an indicator of relapse in acute lymphoblastic leukemia).

 

154. Fifth International Conference on Thalassaemia and the Haemoglobinopathies March 29 - April 3, 1993, Nicosia, Cyprus.

 

155. Variability of Transfusion Practice in Bleeding Association with CPB Transfusion during Neonatal. Intrauterine Transfusion October 29 - 30, 1991.

 

156. American Association of Blood Bank 43rd Annual Meeting. October 23 - 28, 1991.

 

157. Applied Management Skill Development (Series 1) Health Care Professional Educational Series - Management Education October 17 - 19, 1990, Toronto, Ontario, Canada.

 

158. General Aspects of Virus Infection in Bone Marrow Transplant. August 21 - 23, 1990, Toronto, Ontario, Canada.

 

159. American Society Hematology 31^st Annual Meeting, December 2 - 5, 1989, Atlanta, Georgia, U.S.A.

 

160. Autologous Otologist Bone Marrow Transplant in Hematological Malignancy. September 25, 1989, Toronto, Ontario, Canada.

 

161. Management of Pain in Cancer Patient August 4, 1989, Toronto, Ontario, Canada.

 

162. Oncongenies and Introduction to the Concept of Cancer Genetics August 2 - 3, 1989,Toronto, Ontario, Canada .

 

163. Safety in Laboratory Medicine and Quality Assurance in Blood Banking May 2 - 5, 1989 Toronto, Ontario, Canada.

 

164. American Society of Hematology (ASH) 3rd Annual Meeting Dec. 2 - 6, 1988 San Antonio, Texas, USA.

 

165. Practical Approach to Diagnostic Hematological Problems Nov 9 - 13, 1987, Toronto Ontario, Canada ASCP Educational Courses.

 

166. Molecular Biology in Leukemia and Lymphoma August 21 -22, 1987, Toronto, Ontario, Canada.

 

167. American Association of Blood Bank Continual Educational Courses. United States (USA) 1987.

7. Saudi Working Group Initiative for Sickle Cell Disease (SWISS) with Ministry of Health , April 18th ,2019

 

8. Organized workshop of Thalassemia at 29 April, 2019 with CME hrs. 5 at King Abdulaziz University Hospital, with the collaboration of the Saudi Society of Hematology.

 

9. Organized workshop of Hemophilia & bleeding disorder 29-30 April, 2019 at King Abdulaziz University Hospital. CME 10 hrs., with the collaboration of the Saudi Society of Hematology.

 

10. Organized workshop for Sickle cell disease at King Abdulaziz University 30 April, 2019 with CME 10 hrs., with the collaboration of the Saudi Society of Hematology.

 

11. Organized the 2nd Festival of Awareness for Blood Diseases and the Survival for Cancer 2019 April 30, 2019, with the collaboration of the Saudi Society of Hematology.

 

12. Organized the 1st Festival of Awareness of Comprehensive care for cure in the day of International Childhood Cancer February 28, 2019 with the collaboration of the Saudi Society of Hematology.

 

13. Symposium on Haemoglobinopathies King Abdulaziz Hospital & Oncology Center, Ministry of Health (MOH) Nov. 9, 1994 Management of Thalassemic patients

 

14. The 1st Oncology Symposium (Early Diagnosis Treatment) KingAbdulaziz Hospital & Oncology Center (MOH) 9-11 January 1995 Lecture on Immunogloble Level as Indicator of Early Relapse in All.

 

15. Advance Training Program in Post Graduate Hematology.Ministry of Health – King Fahd Hosp. & Research Center, March 11-13, 1995.

 

16. International Symposium on Pathology & Laboratory Medicine College of Medicine, Jeddah, 15-17 Nov. 1997. 5. Hematology / Bone Marrow Transplant Advanced Seminars for Haematology M.O.H. Research for Postgraduate Center.

 

17. ISO 9000 Advanced quality system awareness, 19/2/1997 at King Fahd Military Hospital (KFAFH), Jeddah.

 

18. International Neonatal Symposium, 3-5/March/1997 at KFAFH. Poster Presentation

 

20. Immunoglobulin as an indicator of relapse in ALL in children. June 9-11, 1998.

 

21. World Health Day 2000 at KAUH. Transfusion Medicine Speaker. New trend of transfusion for surgical patients.

 

22. Mini-Symposium of Pediatrics Program and Continuous Medical Education (CME) Mon. 24th April 2000.

 

23. Our experience and the survival of acute lymphoblasts level over 10 years.

 

24. 2nd Annual Hematology and Blood Transfusion Symposium,12-15th Feb. 2000. King Saud University College of Medicine & Post Graduate Center Oral Presentation. “The Safety of avoiding Transfusion”.

 

25. Advances in Molecular Medicine at KAUH in Collaboration with TuftsUniversitySchool of Medicine, Boston, USA. Member in Organizing Committee. Lecturer title (Genetics of G6PD deficiency) Workshop 06-10th May 2000.

 

26. 2nd International Symposium of Laboratory Medicine. On 7-11th Oct. 2000, at K.F.M.R.C. Jeddah.

 

27. Hematology Club meeting in Jeddah, May 7th 2000. Presentation on Chemotherapy Protocols for Acute Lymphoblastic Leukemia's at K.A.U.H & five year survivals of our patients.

 

26. The Eleventh Annual Meeting of the National Working Group on Haemoglobinopathies, Thalessaemias and Enzymopathies; Jeddah Maternity and Children’s Hospital, Oct. 11-12th, 2000.

 

27. Symposium 2001. Updates in Hematology & Transfusion Medicine at King Abdulaziz Hospital & Oncology Center. January 23rd-24th. The Safety of Avoiding Transfusion Pre-Operative.

 

28. Update in Hematology 2001.Wednesday 7th Feb. 2001 at SaudiGermanHospital, Jeddah. “Thrombophilia”.

 

29. The Joint Board for MRCPath Training Program, 2nd Mini Symposium in Hematology and Transfusion Medicine at KAUH in Collaboration of The Royal College of Pathologists U.K, April 10th, 2001. The Prevalence of APC resistance among Saudi population.

 

30. International Conference on Advanced Medicine, KAUH, in collaboration with American College of Physicians Society of Internal Medicine. 23rd – 26th April, 2001. Two abstracts have been accepted in this symposium.

 

31. The prevalence of the most common cause of thrombotic disorders among Saudi patients attending anticoagulant clinic.

 

32. The safety of avoiding transfusion pre-operatively in patients with sickle cell hemoglobinopathies.Pathology Club Western Region. March 31st, 2001, WHO classification of leukemia and lymphoma.

 

33. International Day of Thalessaemia Monday 14th May, 2001. Scientific session. Research Project (Molecular Biology)

 

34. Pre-Marital Screening symposium King Faisal Specialist Hosp. & Research Center, Jeddah - Health Out-Reach & Business Affairs. June 12-14th, 2001. Lecturer & participation in public education.

 

35. Post Graduate Program for continuous medical education – KingFahdHospital 20th January 2002. Lecture New Trend in Transfusion for surgical patients.

 

36. Symposium on Advances in Medicine Services in Saudi Arabia and the Role of Prevention in the Community. January 6-8th, 2002.

 

37. Symposium of What Cardiologist Expect from the Laboratory New Trends. Dr. Erfan & Bagedo Hospital, Jeddah, Saudi Arabia, January 14th, 2002.

 

38. College of Dar Al Hekma Lecture: Is Hereditary Blood Disorder Common in Saudi Arabia? October 3rd, 2002.

 

39. Symposium on (Ideal Utilization of Lab Investigations MOH, Medina Munawarah Ohud Hospital). April 17th, 2002.

 

40. Lecture (The Prevalence of Hereditary Thrombosis Among Saudi Patients). King Abdulaziz University, College of Science (Female Campus)

 

41. Lecture (What is Thalassaemia) The Importance of Premarital Screening. April 28th, 2002.

 

42. E-Learning & E-Health Care King Abdulaziz University April 23-24, 2002.

 

43. Medical Curriculum Development at King Fahd Medical Research Center. May 6-8, 2002.

 

44. Broadcast Education at Saudi TV Channel 1. Kingdom This Morning [(Anemia in Children, Diagnosis, Treatment & Prevention) 27 June 2002].Lecture on Premarital Screening for Public.

 

45. Medical Education through Jeddah Summer Festival 27 /5/ 1423- Monday (8 – July – 2002). Organized by King Faisal Specialist Hospital and Research Center in Jeddah.

 

46. The Distribution of Hemoglobinopathies and G6PD in JeddahPresented at the Second Annual Meeting for Scientific Research. 30-31 March 2003.

 

47. Lecture on Management of VTE in Pediatric Patients. Venous Thrombosis in Clinical Practice. King Fahd Medical Research Center. 20-21 Safar 1423 H, 22-23 April 2003 G.

 

48. Channel Second, Radio Interviewed, Riyadh, KSA. [Saudi Woman on Road to Success] Monday 2003.*

 

49. Management of the crises in sickle cell anemia. In CME Programme of Pediatric Department of Al-Azizia Maternity-Children Hospital, MOH. Held on 22/1/1427 – 21/2/2006 Jeddah.

 

50. ISBT 3rd Transfusion Medicine Course for Arabic Speaking Countries. With the association of WHO & ISBT. 5-7 December 2006 Jeddah.

 

51. Hematology Research Day. December 19, 2006. KFMRC-Jeddah.

 

52. International Symposium on Intersex Disorders: Management and Ethics, Medical Bioethical Conference. 7-8 March 2007. King Abdulaziz University. CME 7 hrs. Accredited.

 

53. Certificate of Attendance of the Workshop of Problem-Based Learning 20-21 March, 2007 at KAU.

 

54. Update Disorders of Thrombosis and Hemostasis. Alkhobar, KSA. King Faisal University, College of Medicine 11 of April 2007. Participated with oral presentation

 

55. *Genetic Counseling in Primary Thrombophilia in Saudi Arabia. CME Accredited 46. Jeddah Hematology Club. May 14, 2007.*Survival and Disease Complication of Thalassemia Major – Experience of King Abdulaziz University. CME Accredited

 

57. Attending and participating in the workshop of "Center of Excellence in Environmental Studies", 17-18 June 2007 in King Fahd Research Center.

 

58. Attending and participating in the workshop of "An Introduction to the Center of Excellence in Genomic Medicine Research", June 2, 2007 in King Fahd Research Center.

 

59. Advances in Laboratory Medicine 29-31 October, 2007 at King Abdulaziz University Hospital, Jeddah, KSA. *Participated with Organizing the Hematology Session and the Workshop.

 

60. 6thGCCGulf Continuous Medical Education Conference. November 5-7, 2007 in King Abdulaziz University Conference and Ceremonial Hall.

 

61. Formulating a Research Proposal Workshop, King Faisal Specialist Hospital and Research Center, Jeddah, KSA 6of November, 2007. CME 8 hrs.

 

62. Intensive Training Course for PBL Training from November 24-December 1, 2007 in King Abdulaziz University Hospital.

 

63. For the Preparation of Female Student for a Better Life Conference. December 3, 2007 in King Abdulaziz University – Female Campus. *Participating with Workshop entitled, "Medical Preparation Pre-Marital". Kalam Nawaem.

 

64. Workshop: How to Develop you Indicators? December 04, 2007 at King Abdulaziz University, Health Education Unit.CME Accredited

 

65. Workshop: Professionalism, December 09, 2007 at King Abdulaziz University, Health Education Unit. CME Accredited.

 

66. Data Entry, Summarization of Data, and Common Statistical Tests-Workshop, 30 January, 2008 at King Faisal Specialist Hospital and Research Center, Jeddah, KSA. CME 3 hrs.

 

67. Workshop: How to Construct MCQ? February 17, 2008 at King Abdulaziz University, Health Education Unit. CME Accredited.

 

68. Workshop: Providing effective Feed Back, February 17, 2008 at King Abdulaziz University, Health Education Unit.CME Accredited.

 

69. 1st Conference of Saudi Society of Internal Medicine and 4th Conference of the Department of Medicine, KAU. From 10-13 March, 2008. CME 23 hrs.

 

70. 4thAcademic Meetings 25-26 of November, 2008, Center of Upgrading the Education in University Female Section.

 

71. Bleeding Disorder/Hemophilia Conference at Children Hospital at Madinah, Manawarah, MOH 7th of May, 2008. *Participation with the Lecture. CME 10 hrs.

 

72. 2008 Update in Transfusion Medicine, Ministry of Health Maternity and Children Hospital, Makkah Blood Bank, 22 Rabi II 1429 28 April 2008. CME 9hrs.

 

73. The Challenge of alternative medicine (Prophet Medicine) In practice. In May 29, 2008. Zamzam Medical service. CME 5 hrs. Jeddah Intercontinental.

 

74. Partners in Progress Special Academic Partnerships Technical Symposium. King Abdulah University Science and Technology (KAUST) October 14 & 15, 2008, Jeddah, KSA.

 

75. Thrombosis and Hemostasis Update Conference 13-14 Dhu Al Qada 1429 (11-12 November 2008) King Faisal Specialist Hospital & Research Center, Riyadh, KSA. CME 11hrs.

 

76. Workshop of Oesteopoierosis at the Center of Excellency of Oesteopoierosis, King Fahad Medical Research Center, KAU, Jeddah, KSA 18th of November, 2008. CME 6 hrs.

 

77. Workshop of Mirde of Scientific signs in Quran & Sunnah 24-25 Dul Quada 1429, November 2008. International Medical Center, Jeddah.

 

78. Courses in Preparing Women’s for married 23/11/1428. Participated with the Lecture.

 

79. Short Courses on Biostatistics Correlation, Regression and Chi-square Test. KFSGH & RC, Jeddah January 22, 2009. CME2 hrs.

 

80. Short Course on Biostatistics. One way ANOVA, Multiple Linear Regression. March 25, 2009. KFSH & RC, Jeddah. CME Accreditation.

 

81. Cancer Cure 2009, 13th May 2009. Participating with Lecture.CME 10 hrs.

 

82. 1st Saudi CML Summit, January 28, 2010, Saudi Arabia. CME 10 hrs.

 

83. Medical Ethics and Research Course and Workshop with Harvard University, USA, at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, February 17,20, 21, 2010.

 

84. New Treatment Strategies for Increasing Survival in Thalassemia Major by ApoPharma and Thamir Al Jazirah March 03, 2010, at Westin Jeddah Hotel, Jeddah, KSA. CME 5 hrs.

 

85. Introduction to Clinical Investigation and Health Outcomes Research at King Abdulaziz University Hospital conducted by Department of Biostatistics and the Center for Continuing Professional Education by Harvard School of Public Health, April 24-26, 2010 at Jeddah, K.S.A.

 

86. 3rd Conference of Eajaz participated with lecture Dar Al Hekma, May 9-10, 2011, Jeddah, KSA. (Journey of Research in Eajaz).

 

87. 3rd Scientific Student Research at King Abdulaziz University. Dec. 12-13, 2011. Participated with 5 researches (1 oral and 4 posters).

 

88. (Health and quality of life outcomes in patient with sickle cells disease at KING ABDUL AZIZ UNIVERSITY HOSPITAL, JEDDAH , KINGDOM OF SAUDI ARABIA). (The prevalence of the most common causes for primary thrombophilia among Saudi patients attending the anticoagulant clinic) (Honey reduces chemo-radiotherapy induced mucositis among Pediatric Cancer patients at King Abdul Aziz University Hospital in Jeddah, Kingdom of Saudi Arabia)

 

89. (Childhood Cancers and the Potential Effect of Environmental Carcinogens). (Role of Nutrition in Sickle Cell Anemia in Patients at King Abdul Aziz University Hospital, Jeddah Saudi Arabia).

 

90. Faculty of Medicine Research Day at King Abdul Aziz University, Jeddah K.S.A. on February 14, 2012. Participated with 1 oral and 3 posters. 81. 1ST National Cancer Survival Day at King Abdul Aziz University Hospital, Jeddah, K.S.A. June 3, 2012.

 

91. SCD Tour 2012 at Intercontinental Hotel, Jeddah, Saudi Arabia on September 13, 2012.CME 8 hrs.

 

92. Phenotype diagnosis of Hemoglobin disorders and possible pitfalls seminar at Radisson BLU on September 25, 2012.Chairperson.Jeddah,KSA.

 

93. 4th Scientific Forum for King Abdulaziz University students: MD Consult and Clinical Key workshop in King Abdulaziz University at Main Auditorium on February 3, 2013. Participated with 3 researches.

 

94. Leu Co Colon Cancer at Main Auditorium, King Abdulaziz University Hospital, Jeddah, KSA on February 26, 2013.

 

95. Leadership Management International, Inc. Effective Personal Productivity, Waco Texas, on February 13, 2013 to March 20, 2013.

 

96. Leadership Management International Inc. Effective Personal Leadership, Waco Texas, on March 30, 2013 to May 11, 2013.

 

97. 2013 Saudi Iron Summit at Hilton Hotel, Jeddah, KSA on May 23, 2013. CME 11 hrs.

 

98. Leadership Management International Inc. Effective Personal Leadership, Waco Texas, on September 04, 2013 to October 02, 2013.

 

99. Leadership Management International Inc. Effective Personal Leadership, Waco Texas, on October 23, 2013 to December 04, 2013.

 

100. College of Dar Al Hekma March 2-3, 2014.

 

101. Participate in the lecture of The Benefit of Pre-Marital Screening at King Abdul Aziz University, Female College, November 2014. Conferences 2015

 

102. Thalassemia Management Update, November 14, 2015, Jeddah, KSA. Participated with oral presentation (The Saudi experience on the effect of Endocrine Complication & it's morbidity in Thalassemia.

 

103. Thalassemia International Federation delegate meeting, King Fahd Medical Research Center November 7, 2015, Jeddah, KSA. Participated with a talk (Survival on disease complications in Thalassemia Major 14 Years experience single institute at King Abdulaziz University, Jeddah, KSA.

 

104. Web of Science, Journal Citations Reports and EndNote training workshops by Thomson Reuters on February 4, 2016 at the King Abdulaziz University, Jeddah, KSA

1. Al Jaouni SK, Adam S, Ayoub D, et al. Immunoglobulin levels as an indicator of relapse in acute lymphoblastin leukemia in children. Accepted as (poster presentation at Montreal,
*Canada, September, 1995) Annual Meeting of Royal College of Physician and Surgeon.

2. Al Jaouni SK, Al Muhayawi S, Gari MH. Safety of avoiding perioperative transfusion in sickle haemoglobinopatheis. (Controlled study).
* 3rd International Saudi Symposium of Hematology & Blood Transfusion in Riyadh, Saudi Arabia. Oral Presentation, 2001.
*Poster Presentation at King Abdulaziz University, Jeddah. The International Conference on Advanced Medicine with collaboration American College of Physician Society of Internal Medicine. 24 April 2001.
* American Society of Hematology (ASH) Meeting abstract # 3535 December 2002
*Presented at Ninth International Thalassaemia Symposium. Palermo, Italy. 17 October 2003.

3. Al Jaouni SK. The prevalence of the most common cause of thrombotic disease among Saudi patients attending anticoagulant clinic.
* Oral Presentation. 2nd International Saudi. Symposium of Hematology & Blood Transfusion in Riyadh 12-15 Feb 2000.
* Poster Presentation. The international conference on Advanced Medicine, King Abdulaziz University with collaboration with American Collage of Physician society of Internal Medicine. 25-26 April 2001

4. Al-Jaouni, SK., Al-Muhayawi, S., Gari, M. Safety of avoiding perioperative transfusion in sickle haemoglobinopatheis (Controlled study).
*3rd International Saudi Symposium of Hematology & Blood Transfusion in Riyadh. Oral Presentation, 2001.
*Poster Presentation at King Abdulaziz University, Jeddah. The international conference on Advanced Medicine with collaboration American collage of physician society of internal medicine. 24 April 2001.
* American Society of Hematology (ASH) Meeting 44 Annual Meeting, Philadelphia, USA abstract # 3535 Dec. 2002
*Presented at Ninth International Thalassaemia Symposium on 17 – 10 – 2003.Italy, Palermo.

5. Sejeny, SA, Quaife, R., Damanhouri, G., Hassounah, F., AlJaouni, S., Omer, A. Frequency and spectrum of -Thalassaemia mutations in the Western Region of Saudi Arabia. Presented at the International Thalassaemia Conference "Malta" 4-9 April 1997.

6. Al Jaouni SK, Molecular clinical correlations of G6PD deficiency in Western Saudi Arabia, 11th Congress of the European hematology Association, June2006, Amsterdam , The Netherlands.

7. Al Jaouni SK, Survival and disease complications of thalassemia major-14 years experience at King Abdulaziz University Hospital, Jeddah, KSA. 11th Congress of the European hematology Association, June 2006, Amsterdam , The Netherlands.

8. Al Jaouni SK, Neonatal screening of G6PD deficiency: Diagnostic challenge and clinical correlation. XXth Congress of International Society of Haematology (ISH) European and African Division (EAD), Oct. 10th -13th, 2009.

9. Al Jaouni SK, Frequency of Hemoglobin disorders in Jeddah, Western of Saudi Arabia. XXth Congress of International Society of Haematology (ISH) European and African Division (EAD), Oct. 10th -13th, 2009.

10. Al Jaouni SK, Prevalence of bone diseases among hematological disorders. XXth Congress of International Society of Haematology (ISH) European and African Division (EAD), Oct. 10th -13th, 2009.

11. Al Jaouni SK, 4 Papers accepted to be presented as a poster presentation in 3rd Pan Arab Human Genetics Conference, March 13-14, 2010.

1. Al Jaouni SK, Smith G. Blood group distribution in the Saudi population.

2. Al Jaouni SK. Distribution of β-thalassemia and hemoglobinopatheis in Jeddah, Saudi Arabia.

3. Al Jaouni SK. Studies on Survival and Disease Complication of Thalassemia Major, Experience of 14 years at King Abdul Aziz University Hospital.

4. Al Jaouni SK, Al Muhayawi S, Gari M. “Controlled Study” Safety of avoiding perioperative transfusion in sickle haemoglobinopathies.
(Abstract presentation at the
*3rd International Saudi Symposium of Hematology and Blood Transfusion in Riyadh). Poster presentation at The International Conference on Advanced Medicine on the 23-26 April 2001, Jeddah, KSA.

5. Co-Author. Determination of the most frequent B-thalassemia mutations in population. Basis for prenatal diagnosis.

6. Co-Author. Haplotypes of sickle cell anemia in the western province of Saudi Arabia.

7. Al-Jaouni SK, et al. Glucose 6 Phosphate Dehydrogenase Deficiency. Neonatal Survival: Frequency and Clinical Significance.

8. G.A. Raouf, W. A. Ekhateeb, S Jaouni, H. Toma, M. Qari, K. Elkebba, T. A. Kumosani. Infrared Spectroscopy of Human Bone Marrow: Evidence of Structural Changes During Acute Leukemia. (Published).

Research 2019 - 2020

Approved grant from DSR:

1. Effect of Novel of a Nano-formulation of Pomegranate on the chemoresistance and nephrotoxicity of cisplatin-treated animals.

2. Evaluation of the Anti-Diabetic efficacy of a novel nano-formulation of Ellagic acid in rats.

3. Effect of Honey on SCD

4. Novel therapy to remove iron overload from the liver in thalassemia disorders.
   Prof. Soad K. Al Jaouni, Dr. Lamia Jamjoom & Mrs. Sabrin Khooli

 

Research 2013- 2018

 

See publication lists

 

Research 2011/2012

 

1. Medical Student Awareness of Neonatal Screening of Hemoglobinopathies & G6PD thru questionnaires.
2. Quality Control of Life in SCA thru patient health questionnaires (PHQ).
3. Retrospective Study to Detect the Prevalence of the most common causes for the Primary Thrombophilia attending the Anti-Coagulant Clinic from 1998 to 2008.
4. A Control Study to use and Integrative Approach by Natural Honey with a Standard Care to Reduced the Oral Mucositis in Pediatric Cancer Patients as a Supportive Measures.
5. To Assess the Outcome and Improvement in the Quality of Life among Chronic Blood Diseases (Hemoglobinopathies & Cancer Patient) by Improving their Diet Habit.
6. Using a New Integrative Approach with a Natural Product called PM701with a Conventional Chemotherapy in a Refractory Relapsed Cases in Pediatric Hematology/Oncology patients.
   • There is a successful report of the pilot study of a relapsed refractory case of stage IV Hodgkin’s Disease.
   • There is a seven studies in Tissue Culture and Animal Studies for the effectiveness of this natural agent as a selective apoptosis in cancer cell.
   • Attached the research proposal with the reference
7. Evaluation of Bone Complication and Osteoporosis in Pediatric Oncology Patient.
8. Childhood Cancers and the Potential Effect of Environmental Carcinogens.
9. Prevalence of Endocrine Complications and Osteoporosis among Children and Adolescents with SCA .
10. The Role of Cupping in Severe Sickle Cell Disease.
11. The Role of Consumption of Phoenix dactylifera L. in immune compromise patient.
12. Retrospective Study about Burkitt’s Lymphoma. The Experience of King Abdul Aziz University Hospital.

King Fahd Research Center/King Abdulaziz University Hospital

 

Research 2009/2010

 

1. Endocrine Complication in Thalassemia Patient
2. Medical Student Research
   • Newborn Screening Questionnaire
   • Neonatal Jaundice
   • Warfarin Resistant in Anticoagulant Clinic
3. Clinical Trial Phase II with PM 701
4. Sickle Cell Anemia and Infection
5. Supportive Measure in Pediatrics Hematology/Oncology Patients

 

Research for Haematology Department

at King Fahd Research Center

Granted/Ungranted Research

Researches 2008/2009

 

1. A Noval Methods Detection of Residual Disease of Acute Lymphoblastic Leukemia among Children by Using Infrared Spectroscopy (Co-Investigator)

2.  Experimental Use of PM 100 in Ulcers and High Dose Chemotherapy, Radiotherapy Due to Severe Neutropenia in ALL Children (Principal Investigator).

3. Applications of Diagnostic Procedures in the Diagnosis of G6PD Deficiency including the Molecular Sequencing in Neonatal Screening (Principal Investigator).

4. The Association between Thrombocytopenia and Helopactor Infection (Principal Investigator).

5. Application of Cupping in a Control Study for Management of Sickle Cell Vaso- Occlusive Crisis (Principal Investigator).

6. The Prevalence of Bone Disease among Acute Lymphoblastic Leukemia in Children (Principal Investigator).

7. Clinical Trial 2 in the treatment of resistant to chemotherapy in pediatric oncology patient using a noval experimental therapy PM 701.

 

2007/2008

 

1. G6PD Genotypeby Gene Sequencing (Granted) Dr. Soad Al-Jaouni. (Principal Investigator)

2. Uses & Application of Fouria Transform Infrared (FTIR) Spectroscopy in Analysis, Early Diagnosis and Follow-up of Patients with Blood Disease.

3. Study of von Willebrand Disease Phenotype among Saudi Patient Multicenter Trial.

4. The Prevalence and Incidence of Hemoglobinopathies and G6PD in Western Region of Saudi Arabia. Dr. Soad Al-Jaouni. (Principal Investigator)

5. Normal and ReferenceRanges of the CBC Result among Saudi Population. Dr. Soad Al-Jaouni. (Principal Investigator)

6. Laboratory Investigations for the Ideal Screening Tests for G6PD Deficiency. Dr. Soad Al-Jaouni. (Principal Investigator)

7. Bone Disease Among Thalassemia Major Patient Dr. Soad Al-Jaouni, Dr. Abdulmoien Agha

8. The Prevalence of Bone Disease IN Sickle Cell Anemia and Hematological Diseases Dr. Soad Al-Jaouni. (Principal Investigator)

9. To Study the Social Support and Complication Among Thalassemia Major Patient Multicentral Study in Saudi Arabia. Dr. Soad Al-Jaouni. (Co-Investigator)

 

2006/2007

 

1. Comparison of Standard Treatment of Hepatitis C and Alternative Therapy from Alternative Medicine:  a Randomized Controlled Trial.  (Principal Investigator).

2. A control study group of treatment of Helicobacter pylori and Role of prevention of Malt lymphoma. (Principal Investigator). *Al Jaouni SK, Dr. Nasrat AM, Akbar H, Dr. Falata H.

3. Infection and Sickle Cell Anemia Dr. Fatin Al-Sayes, Dr. Soad Al-Jaouni, Dr. Asif Fatani

 

2005/2006

 

1. New Alternative Medicine Can Cause Selectively Cell Death for Cancer Cell. (Co-Investigator).

* Sent for Patent

 

Research for Haematology Department

at KingFahdResearchCenter

Granted Research

2003

 

1. Initiate A Primary Prevention Program for Hemoglobinopathies

            * S. Jaouni, M. Qari, A. Abozneda, S. Matboli, B. Beirouti.

 

Research for Haematology Department

at KingFahdResearchCenter

Ungranted Research

2003

1. HypercoagulableState in Sickle Cell Anemia during Vasoocclusive crisis * G. Zaher, S. Jaouni.

2. Sickle Cell Anemia and Pattern of Infection * F. Al-Sayes, S. Jaouni, F. Gazzaz, A. Fatani.

3. Correlation between Serum Ferritin and MRI Results in Iron Overload Secondary to Chronic Transfusion Programs * S. Adam, S. Jaouni.

 

Research for Haematology Department

at KingFahdResearchCenter

2002/2003

 

1. G6PD Genotype Among Saudi Patient * S. Jaouni, M. Qari, I. Ashankyty. Completed.

2. Prevalence of b-thalassemia Among Saudi Population at Jeddah * S. Jaouni. Completed.

3. Neonatal Screening of G6PD * S. Jaouni, Completed.

 

Research for Haematology Department

at KingFahdResearchCenter

1989/2001

1. Comprehensive newborn screening program for detecting the most common inherited blood disorders and initiating a comprehensive care program . (Principal investigator). Completed. Granted #002/420

2. "Frequency and spectrum of b-Thalassaemia mutations in the Western Region of Saudi Arabia". (Co-author). Completed.

3. DNA damage and repair in leukemia / lymphoma patients determined by Single cell gel electrophoresis and treatment outcome (Co-investigator). Granted #009/421

4. Neonatal Screening for G6PD deficiency (Principal Investigator). Completed.

5. G6PD Genotype among Saudi Patients (Principal Investigator). Completed.

6. Pre-marital screenings for detecting the most common inherited blood disorders and initiate a primary prevention program. (Principal Investigator). Completed.

7. A National Program as Community Base to Control the Hereditary and Congenital Disorders by Applying Comprehensive Newborn Screening. (Principal Investigator).

8. Initiate a primary prevention program for hemoglobinopatheis (Principal Investigator) Grant #013/423

9. Lipid profiles in sickle cell anaemia and thalassaemia patients. (Co-investigator).

10. Prospective study among Saudi donors for detection and prevalence of hereditary hemochromatosis in the Western region. (Co-investigator).

11. Molecular Characterization of G6PD Deficiency among Saudi Arabia Patients. Grant # 426/026.  (Principal Investigator). Gene sequencing.

1. Member in postgraduate education in MRCPath (U.K.) London; in Hematology at KingAbdulazizUniversityHospital, 1995 (to present) & Coordinator of post graduates at KingAbdulazizUniversityMedicalCenter (2002).
2. Member in the oncology group of the KingAbdulazizUniversityHospital, 1998 – present.
3. Member in the organizing committee in the advance course in Molecular Medicine, 1998.
4. Member of Scientific Committee of Saudi International Transfusion Medicine Symposium, Jeddah – Saudi Arabia, 22-25 March 2004.
5. Chairman of Haematology Oncology Task Force at Hematology Department, 2003 until present.
6. Coordinator of Medical Education of the Haematology Department. 2003.
7. Organizer of Diagnostic Workshop for Hemoglobinopathies, May 9, 2004.
8. Member of Scientific Research, Faculty of Medicine, 2005.
9. Chairman and Head of Hematology Department at KAUH, July 2005.
10. Member of Scientific Committee on National Symposium on Food Pollution and its Health Consequences, 24-26 February 2005.
11. Organizer of the “Diagnostic Workshop in Hereditary Blood Disorder at Molecular Level”, May 2005.
12. Member of Group of Immunity and Lymphatic Blood. 2005 until present.
13. Member of Ethical and Research Committee, 2005 until present.
14. President of the 1st International Conference in Pediatrics Hematology/Oncology, November 2005.
15. Organizer of Workshop of Nursing and Musculoskeletal of Hereditary Bleeding Disorders. International Saudi Symposium of Hemostasis and Thrombosis (INSSH). November 2006.
16. In charge of “Career Day” Fourth Committee at the MedicalCollege, Female College Campus. In1999.
17. Member in Quality Improvement, 2001 – 2003.
18. Coordinator of Lymphatic Immunity Blood System, 2007.
19. Member of Tumor Board at KingAbdulazizUniversityHospital, 2008.

1. Peer reviewer of Applied Hematology Journal and Associate Editor.
2. Peer reviewer for the KingAbdulazizCity for Science & Technology for the Project Founded by – Riyadh, Saudi Arabia
3. Peer reviewer for Annals of Saudi Medicine – Riyadh, Saudi Arabia
4. Peer reviewer for Saudi: Med J., Riyadh Saudi Arabia
5. Peer reviewer for the Journal of King Abdulaziz Medical Sciences, Jeddah, Saudi Arabia.
6. Peer reviewer for the King Saud University Research in Riyadh, KSA.
7. Associate Editorial Board in the Journal of Applied Hematology. The Official Journal of Saudi Society of Hematology.
8. Reviewer in Journal of Public Health and Epidemiology.
9. The Egyptian Journal of Schistosomiasis, Infectious and Endemic diseases.
10. Peer reviewer for the Clinical Research in King Abdullah International Medical Research Center (KAIMRC), King AbdulAzizMedicalCity, National Guard Health Affairs, Riyadh, KSA.
11. Peer reviewer of the Journal Ibencina Medical Journal.
12. Peer reviewer of the Journal of Platelets.

• Investigator Meeting, 15-16 March 2004; Protocol CICLG70A2402 Novartis, Dubai, UAE An open-label, multi-center trial on efficacy & safety of long-term treatment with ICL670 in Thalassemic patient with Transfusional hemosclerosis.
  *Co-investigator
• The Second Middle East Thalassemia Investigators and Thought Leaders Meeting, October 2-3, 2003, Luxor-Aswan, Egypt.
Thalassemia Investigations and Thought Leaders Meeting, 26-27 November, Marriott Dead Sea – Jordan 2004.
• The Fourth Middle East Thalassemia Investigators and Thought Leaders Meeting, September 01-03, 2005, Amsterdam, Holland.
  
• International Study for Sickle Cell Anemia and Low Molecular with Heparin 2005-2006.
• articipate in the Consensus Opinion (Guidelines for managing painful vaso occlusive crisis of sickle cell anemia) Alexandria 24 to 26th of April, 2008.
• Delegated in Marquis Who’s Who Publication Board, Who’s Who in the World Twenty Sixth Edition, 2009.
• Delegated and invited to participate in International Exchange Education from Mayo Clinic College of Medicine USA: People to People Citizen Ambassador Programs’ Hematology and Oncology Delegation to Vietnam and Colombia in October 2010.
• Participation in the Clinical Trial Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285. Protocol H7T-MC-TADO(b). A Phase 3, Double Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients with Sickle Cell Disease.

• In-charge of Community Education in Health and General Knowledge at Home Health District.
• Awareness Campaign in the Community to Prevent Inherited Blood Diseases.

A Professor/Dr. &  Consultant of Hematology & Pediatric Hematology Oncology.

 Senior Researcher and Lecturer more than 30 years experience as Academic and Senior in Research

• Developed the Department of Pediatric Hematology/Oncology at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. 1990.
  • Developed the diagnostic work up for hematological malignancy by flow cytometry and genetic with collaboration with another hospital private and National Guard Hospital and diagnostic work up for pediatric oncology with the Pathology Department.
  • In-charge and Head Division of Pediatric Hematology/Oncology at KAUH.
• In early 1990 established a diagnostic lab for inherited blood disease (thalassemia, hemoglobinopathies and G6PD deficiency) and put the policy and procedures in Blood Bank for the safety of donors for thalassemia e.g. (screening for hepatitis C).
• Initiate the Multi-disciplinary treatment for inherited blood disease in Pediatric Hematology/Oncology, 1991.
• Initiate a Prevention Program of Hemoglobinopathies at King Fahd Military Hospital. 1996.
• Initiated the Prevention Program for the Inherited Blood Disorders by Public, Medical Education & Pre-marital and Neonatal Screening at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. 1998.
• Discover a successful treatment of Advanced Progressive Systemic Mastocytosis.
• A registered patent discovery of a new experimental successful treatment for cancer.
  Patent No. 04250314 date 27/09/2004.
• Discover a successful treatment of Advanced stage for Hodgkin Disease resistant to the usual adjuvant chemotherapy treated with experimental PM 701. Published as abstract in blood Journal of the American Society of Hematology, November 16, 2008. Finished a Clinical Trial I with this experimental medicine in 16 patients.
• Discover a novel variant gene of G6PD for the Saudi population.
• Initiated Hematology Research Day, Award for the Junior Researcher in Hematology.
• Initiate the classification of complementary and supportive medicine for research.
• Initiate a Hematology Endocrine Service at King Abdulaziz University Hospital, 2005.
• International Research Project with University of Toronto Canada, July and August, 2008.
• Working to establish Hemoglobinopathies Reference Laboratory.
• External Examiner for the Fellowship of Clinical Pathology King Faisal University, Dammam, KSA
• External Examiner for The National Cancer Institute (NCI) for Cairo University, Egypt for Doctor ship Degree, 2010.
• Head Division of Research in Eajaz from 2008 up to present.
• Al Jaouni SK. Primary thrombophilia in Saudi Arabia. Saudi Med J 2003; 24(6):614-616.
  This article had been  selected August 20, 2011 in Bio Med Library as Top 10    Published in this domain.
• Al Jaouni SK., Jarullah, JM., Azhar EI., Moradkhani K., Molecular
  Characterization of Glucose-6=Phosphate Dehydrogenase Deficiency in Jeddah, KSA.
  BMC Research Notes. 4:436. doi: 10.1186/1756-0500-4-436.
  (Top 20 publication by BioMed Lib 2012). Impact Factor: 2.7
  
• Elected to be a Member of People to People Ambassador from United States 2012.
• Director of Yousel Abdul Latif Jameel Scientific Research of Prophetic Medicine, 2012.
• Initiate to establish a bone marrow transplant for benign disorder of inherited hemoglobinopathies with University of Rome, Italy.
• External examiner at National Institute of Cancer for Pediatric Oncology , Cairo, Egypt.
• Initiate the registration of Patent Research from the Scientific Chair.
• Supervised Master and Doctorship (PhD) Thesis.

Doctor of Philosophy in Biotechnology (Molecular Characterization of Erythrocyte Glucose-6. Phosphate Dehydrogenase Deficiency in Jeddah, Saudi Arabia) January 2015.

Issued US Patents:
• Al Jaouni et al,
Patent No: US 9.861.675 B1
Date of Patent: January 9, 2018
Methods of treating ischemic heart disease
51180PRO-NY
• Mousa Shaker (USA), Al Jaouni Soad (KSA): Using Nano Co-encapsulation for the Prevention and Treatment of Various Disorders. US Patent 15,011,976; 02/2016 United States Patent Application 20150223451 , Kind Code A1 Mousa; Shaker A. ; et al.

International Prize of King Faisal in Medicine